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CD44 on solukalvon reseptoriproteiini, joka sitoutuu reversiibelisti hiilihydraattiligandiinsa,
hyaluronihappoon. Tämä proteiini-hiilihydraattivuorovaikutus mahdollistaa sekä normaa-
lin solumigraation, kuten valkosolujen pyörimisliikkeen, että pahanlaatuisten syöpäsolu-
jen tunkeutumisen terveisiin kudoksiin muodostaessaan etäpesäkkeitä verenkierron väli-
tyksellä. Normaali solu tarvitsee näin ollen tehokkaita mekanismeja CD44:n ja hyaluro-
nihapon vuorovaikutusaffiniteetin säätelyyn. Näiden säätelymekanismien tunnistaminen
on osoittautunut kuitenkin haastavaksi. Perinteisiä laboratoriokokeita on vaikeuttanut
käytettävien menetelmien heikko mittatarkkuus nanoskaalan ilmiöiden kuvaamisessa. Tie-
tokonesimulaatioiden luotettavuutta ovat puolestaan rajoittaneet sekä simulaatiomallien
epätarkkuudet että laskentaresurssien puute.
Tässä tutkimuksessa käytämme atomaarisen tarkkuuden omaavia molekyylidynamiikka-
simulaatioita selvittämään, kuinka hyaluronihappo sitoutuu ihmisen villityypin CD44-
proteiiniin. Tutkimus keskittyy erityisesti kolmeen potentiaaliseen säätelymekanismiin:
hyaluronihapon pituuteen, proteiinin glykosylaatioihin ja proteiinin rakennemuutoksiin.
Löydöksemme ovat varsin merkittäviä. Hyaluronihappo-oktameerin adsorptiolle lasketut
vapaaenergiaprofiilit muun muassa osoittavat, että yksittäisen CD44-hyaluronihappovuoro-
vaikutuksen voimakkuus on peräti 25 kJ mol−1. Lisäksi glykosyloimalla proteiinin amino-
happotähteet Asn25, Asn100 ja Asn110 näytämme, että Asn25:een liitetty varausneutraali,
viisi sokeriyksikköä sisältävä hiilihydraatti estää normaalit CD44-hyaluronihappovuorovai-
kutukset laskien sitoutumisen voimakkuutta 40 %. Kaiken tämän ohessa simulaatio-
datamme osoittaa aiemmin vahvaan sitoutumiseen yhdistetyn konformaatiomuutoksen ole-
van itse asiassa molekylaarinen mekanismi, joka irrottaa proteiinin pintaan sitoutuneen
hyaluronihappojuosteen.
Tutkimus paljastaa miten solu säätelee CD44:n ja hyaluronihapon sitoutumista toisiinsa.
Uusi tieto voi edistää uudenlaisten lääkkeiden ja hoitomuotojen kehitystä ja kohdentamista
esimerkiksi syövän hoitoon. Lisäksi tämän tutkimuksen tulokset hyödyttävät muiden vas-
taavien kalvoreseptoreiden proteiini-hiilihydraattivuorovaikutusten selvitystyötä.
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CD44 is a transmembrane receptor protein binding its carbohydrate ligand, hyaluronic
acid (HA), in a reversible fashion. In addition to enabling normal cell migration, such as
the rolling of white blood cells, these carbohydrate-protein interactions are exploited by
malignant cancer cells metastasizing through the blood stream. A normal cell therefore
requires effective regulatory mechanisms for controlling the binding affinity between CD44
and HA. Earlier studies addressing this topic have, however, been unable to identify these
regulatory mechanisms. More precisely, traditional wet-lab experiments, limited by their
spatial and temporal resolution, have been inadequate in describing transient nanoscale
phenomena, such as the ligand binding. Previous computer simulations have, on the other
hand, been limited by both veracity of simulation models and availability of computational
resources.
In this Thesis, we use all-atom explicit-solvent molecular dynamics (MD) simulations to
study the adsorption of HA oligomer to a human wild-type CD44 HA binding domain
(HABD). In practice, we explore the role of three potential regulation mechanisms: size
of the ligand, glycosylation of the protein, and conformation of the protein. First, free
energy profiles for the adsorption of HA octamer, revealing the strength of an individual
CD44-HA interaction to be over 25 kJ mol−1, suggest ligand binding to be irreversible.
Second, by glycosylating the HABD at residues Asn25, Asn100, and Asn110, we show the
first of these residues to block most of the native binding interactions. As a result, the
strength of the adsorption is, at least when using charge-neutral core pentasaccharides as
the attached carbohydrates, decreased by 40 %. More surprisingly, the simulation data
reveal a conformation transition previously correlated with high-affinity binding to, in fact,
act as a molecular mechanism repelling the bound HA oligomer, and thereby dynamically
regulating the biological activity of the CD44.
The findings of this study uncover how the binding of HA to its CD44 receptor is regulated.
This information may facilitate the design and targeting of novel drugs and therapies
against conditions, such as cancer. Lastly, the insight from this study is of potential value
when considering the carbohydrate-protein interactions of other cell surface receptors.
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11. INTRODUCTION TO THE WORLD OF
SUGARS AND SIMULATIONS
Cells are the basic units of life. Every living organism is built from these tiny,
diverse, and fragile objects that have perfected themselves through billions of years of
evolution. Not long ago, it was still thought that cells would possess some mysterious
force of life over the rest of the universe. Today it is, however, known that they
are driven by the same laws of physics that, for example, make water to boil in
high enough temperature or control the organization of electrons around a nucleus
of an atom. This realization has not removed any of the thrill of studying these
amazing biological constructs, but on the contrary, has made it even more exiting
and rewarding. Indeed, understanding the cells and the various interactions they
make is not only vital for perceiving the nature, but may profoundly increase the
quality of our lives. When considering the cellular interactions in particular, it is
not surprising that the interface between the cells and their immediate surroundings
comprises the most interesting area of research.
On the surface of cells, on the border of two environments, lies a layer called
glycocalyx [1–4]. It is a thin gel-like coat lining most of the cells from simple
bacteria to higher eukaryotes like the animal cells. Glycocalyx consists of carbo-
hydrates, proteins, and other biological components attached to a cell membrane
either chemically by covalent bonds or physically by electrostatic interactions [4]. It
forms a functional interface constantly sensing the environment, mediating cellular
recognition and adhesion, and gating the molecules that try to enter or leave the
cell, thereby rendering cellular interactions complex and well regulated events [5].
In this regard, the most important components of the glycocalyx are the adhesion
molecules, cell surface proteins that control the cell-cell and cell-matrix interactions.
Due to its central role in cellular proliferation, one of the most interesting func-
tional units of the glycocalyx is an adhesion molecule called CD44 [6]. It is a ubiq-
uitous multistructural and multifunctional cell surface protein that, as its hallmark
function, interacts non-covalently with a carbohydrate polymer called hyaluronic
acid (HA) [7]. This adhesion interaction maintaining a vast HA network around
the cell is also sensing the surrounding microenvironment and guiding the cellular
functions through multiple biochemical signaling pathways [8]. As a result, CD44
has a vital role in cell survival, growth, and motility. Proper function of these funda-
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mental processes is required for processes such as white blood cell homing, healing
of injuries, embryonic development, and controlled cell death.
Given the central role of CD44-HA interaction in normal cellular homeostasis,
and the vast abundance of both species, it is clear that their interactions must be
regulated extensively [6]. Indeed, reflecting the dynamic nature of these interactions,
some cells at a particular developmental stage need the HA binding ability for their
normal functions, whereas other cells at a different phase of the development do not
adhere to HA at all [9]. One very efficient way utilized by most cells to alter protein
structures, and therefore their ligand binding properties, is to glycosylate them by
covalently linking carbohydrates to their surfaces [10], or also by allowing changes in
their conformations. Failure in these normal regulatory mechanisms, however, leads
to severe pathologies and malignancies. Indeed, CD44 has been repeatedly linked
to conditions such as prolonged inflammation and cancer propagation [11, 12]. As a
matter of fact, CD44 has been confirmed to be a major player in the spread of tumor
metastases, thus highlighting its central role in cellular function and rendering it as
an intriguing subject for further research.
CD44 has been studied extensively for two decades. In addition to a high number
of experiments concentrating on its pathophysiology, a range of studies have also
focused on the molecular level details of its structure. The goal has been to fully
understand the factors affecting the CD44-HA interplay. Overall, techniques such
as mutagenesis assays [13, 14], spectroscopy measurements [15, 16], and computer
simulations [17, 18] have been applied, yet many details of the binding process are
still missing. Most importantly, the previous endeavors of deciphering this surpris-
ingly complex chain of events have not accounted for the modular structure of CD44,
with several glycosylation possibilities altering the binding process. Nor has anyone
evaluated the details of how the receptor recognizes different HA sizes. Furthermore,
due to somewhat controversial results between previous NMR spectroscopy [19] and
x-ray crystallography studies [16], the biological relevance of the conformational
changes in the structure of CD44 has remained unclear.
Solving the precise details of CD44-HA interplay could also have pharmacological
implications. In other words, knowing how the regulation of the interaction is con-
ducted in nature may facilitate the design and the targeting of novel drugs against
malignancies such as cancer. Moreover, this information is of potential value in
unraveling the function of other HA binding proteins [20] or more generic protein-
carbohydrate interactions.
Admittedly, the study of these biomolecules is not a straightforward task. Exper-
imental methods comprising the backbone of the research are often limited by the
dynamic and delicate nature of soft matter systems such as the glycocalyx [21]. How-
ever, while the importance of experimental methods should not be underestimated,
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they can be complemented with a variety of different computational methods. One
particularly appealing technique for studying biological phenomena that occur at
energy scales of weak physical interactions, like thermal fluctuations, is a method
called molecular dynamics (MD) [22]. Despite having some inherent weaknesses of
its own, MD is nowadays widely used to simulate the dynamics of biological many-
body systems.
In this Thesis we employ atomistic MD to explore the role of glycosylation and
HA chain length in CD44-HA interplay. We present several model systems, with
three distinct CD44 glycosylation schemes, two CD44 conformations, and three HA
sizes. Most importantly, we measure the effect of glycosylation to HA binding
by calculating the thermodynamic binding free energies for the adsorption of HA
oligomer to its binding site in CD44 with and without the added carbohydrates.
Furthermore, comprehensive binding profiles and free energy profiles reveal how HA
fragments of different size are recognized. Based on our simulation data, we also
question the biological relevance of the conformational changes in stabilizing the
carbohydrate-protein interaction.
Given the lack of knowledge about the glycocalyx and its components in general,
our work is like solving a puzzle. However, instead of having all the ready-made
pieces, we need to build them ourselves from scratch. The project may also have
far-reaching implications, as it is an integral part of a larger attempt to model the
whole glycocalyx-layer with atomistic precision.
This Thesis is divided into six chapters. The next chapter presents the biochemi-
cal background of glycosylation along with the detailed structure of the glycocalyx.
The third chapter then gives a state-of-the-art review on CD44 and its functions
with an emphasis on the interaction with HA. Next, the fourth chapter describes
the computational methodology employed in this study. Namely, it explains the
theory behind classical MD methods and related free energy calculations and lists
the used model systems and simulation parameters in detail. The fifth chapter
presents the simulation results and compares them to previous ones obtained from
both experiments and computer simulations. The last chapter then reviews the
main results, discusses their biological relevance, and concludes by contemplating
the possible future directions.
42. HYALURONAN-RICH GLYCOCALYX ACTS
AS A FUNCTIONAL INTERFACE OF CELLS
Glycocalyx is a fascinating and still somewhat mysterious layer lining various cell
types. Due to its vast amount of molecular components it renders the cell-cell
contacts totally different from those of simple liposome-liposome interactions [21].
The term "glycocalyx", referring to a sweet husk, was first used by Bennet et al. [23]
who discovered in 1959 with electron microscopy that a polysaccharide coat was
surrounding several vertebrate blood capillaries. Ever since, this intriguing and
complex structure has been called with many names, such as "pericellular matrix"
(PCM), "cell coat", or is simply referred to as the carbohydrate layer. Similarly,
the definition of glycocalyx has various interpretations in the narrow yet constantly
growing literature around the topic.
Although recently the endothelial glycocalyx [1, 3, 4, 21, 24] has evoked consid-
erable interest due to its conspicuous appearance, other cells, too, express carbohy-
drates on their surface [2, 25, 26]. In this Thesis, the glycocalyx is given a broad
definition referring to every carbohydrate-bearing material on the surface of bacteria
and almost all animal cell types. In fact, the slime on the surface of a snail, fish,
or intestinal epithelium can all be regarded as a glycocalyx. It should be noted,
however, that this study focuses only on animal cells, and more precisely, on human
cell types.
Furthermore, the distinction between the glycocalyx and the extracellular ma-
trix (ECM) is not always properly defined. Indeed, despite sharing some integral
components, such as the HA polymers, these two structures confer totally different
functions. For instance, the ECM produced mainly by fibroblasts, chondrocytes,
and osteoblasts, forms the mechanical platform to which other cells then adhere to.
This concept is remarkably well illustrated in the decellularized organs where only
the extracellular framework remains [27, 28]. In contrast, the glycocalyx, forming a
functional interface between cells and the ECM, executes mainly dynamical adhesion
and gating functions.
This chapter describes the biological milieu in which the CD44-hyaluronan inter-
action takes place in. The first section gives a brief introduction to basic biomolecules
and their glycoconjugates, especially the ones important for the present study. The
second section then presents the state-of-the-art knowledge on the composition of the
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Figure 2.1: Collectively, glycocalyx and plasma membrane are formed from lipids, pro-
teins, and sugars that combine to create several conjugate molecules.
glycocalyx. The last two sections briefly review the main properties and functions
of HA, which is an integral part of our simulation models.
2.1 From Simple Biomolecules to Elaborate Glycoconjugates
Every cell expresses a distinct but vast number of biological macromolecules. They
are the basic structural and functional units of our bodies and have been con-
served through evolution due to their ability to carry out specific tasks in sus-
taining cellular functions. In practice, these molecules can be just small metabo-
lites working as cofactors for larger enzymes or longer polymers with molecular
weights over 500 kDa. Three basic classes of biomolecules−− proteins, lipids and
polysaccharides−− coexist in the complex environment of the glycocalyx as illus-
trated in Figure 2.1 [4, 29, 30].
Proteins are long polymers of amino acids. From all the biomolecules they have
the widest array of functions. Indeed, proteins act as catalysts, signal receptors,
structural elements, and transporters. Lipids, on the other hand, are a broad class of
amphipathic molecules that in a biological milieu serve e.g. as signaling molecules,
structural components of membranes, storages of fuel, and pigments. Biological
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lipids usually comprise a hydrophilic head group and two hydrophobic fatty acid
chains connected to a certain backbone molecule. While cell membranes are primar-
ily constructed of biological lipids, ordinary substances like waxes, vitamins, and fats
can also be considered as lipids. Physically, membranes act as 2D fluid layers stuffed
with transmembrane proteins having different compositions and compartments, such
as cholesterol-rich lipid rafts.
Lastly, polysaccharides or carbohydrates are polymers of either mono- or disac-
charides joined together by glycosidic bonds. These monomers include an array of
simple sugars, such as glucose or galactose. In general, polysaccharides have two
major functions inside the cells. First, like lipids they serve as energy-rich fuel
stores releasing chemical energy, stored to their glycosidic bonds, when required.
Second, polysaccharides are important structural elements in plants and bacteria,
forming rigid cell walls around them, thereby providing them mechanical stabil-
ity. Fundamental knowledge of all the aforementioned biomolecules is available in
many excellent textbooks concerning proteins [26, 29, 31], lipids [26, 29, 32] and
polysaccharides [26, 29, 33].
Glycosaminoglycans or simply GAGs encompass a special class of biopolysac-
charides unique to animal cells. Unlike homopolysaccharides like starch or glyco-
gen, they are linear disaccharide polymers that have been modified by sulphation
or deacetylation of varying degrees [4]. In practice, disaccharides always comprise
a uronic acid and a hexosamine, where the latter is either N -acetylglucosamine
or N -acetylgalactosamine. Furthermore, the uronic acid is in most cases either
d-glucuronic acid or l-iduronic acid [26]. The carboxylate group in uronic acid to-
gether with extensive sulphation leaves GAGs with a highly negative charge density.
As a result, their conformation is largely dependent on sulphation patterns [34] and
also allows specific recognition by carbohydrate-binding proteins, such as selectins.
Furthermore, owing to the high negative charge density, GAGs usually assume an
extended helix conformation in solution with carboxylate groups in alternate sides
of the sugar chain.
In addition to roles as storage fuels and structural materials, polysaccharides
act as information carriers. On the surface of a plasma membrane, they form the
most prominent part of the glycocalyx that provides recognition sites for extra-
cellular molecules and pathogens, thus enabling communication between cells and
their surroundings. In comparison, inside a cell, sugars are employed in labelling
proteins for transport, localization, or destruction. Indeed, almost always sugars,
especially oligosaccharides (polymers with less than 20 monomers [33]), are cova-
lently attached to a protein or a lipid to form so-called glycogonjugates [26]. These
conjugate structures are named as glycoproteins and glycolipids unless the carbohy-
drate content exceeds that of the lipid or the protein, in which case they are referred
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to as lipopolysaccharides and proteoglycans, respectively [33].
Proteoglycans are ubiquitous glycoconjugates of the PCM and ECM. They con-
stitute one or more GAGs covalently linked to a protein that can be either attached
to a membrane or secreted to the ECM. At first, proteoglycans assemble in the
endoplasmic reticulum (ER) and in the Golgi complex, where a range of enzymes
attach GAGs to serine (Ser) residues of the core proteins via a so-called tetrasac-
charide bridge. Later, additional modifications in the Golgi will determine the final
destination of the newly synthesized proteoglycans. One possible target destination
is, for example, the glycocalyx where the proteoglycans bind extracellular ligands,
thus activating them, or simply help to sustain an ideal local concentration of these
soluble substances. Some secreted proteoglycans also form enormous supramolecular
complexes called aggregates. These huge assemblies then contribute to the strength
and resilience of many mammalian tissues [26].
Another important class of protein-sugar conjugates are glycoproteins. Like pro-
teoglycans, they also have several carbohydrates of varying complexity attached to a
core protein. The main difference between the two classes is, however, that glycopro-
teins have generally much shorter (2-15 monomers long), more branched, and more
structurally diverse sugar residues attached via special glycosidic linkages [4]. Im-
portantly, only a few carbohydrate species participate in these peptide links, namely
N -acetylglucosamine (GlcNAc), N -acetylgalactosamine (GalNAc), galactose, man-
nose, xylose, and l-arabinose [33]. Glycoproteins are mainly found in the ECM,
glycocalyx, and blood, although some cytosolic proteins can also be glycocylated.
Demonstrating the vital role of these modifications, 50 % of all of the mammalian
proteins are glycocylated and 1 % of all the genes coding for enzymes relate to gly-
cocylation [26]. The attached oligosaccharides then shield the protein from cleavage
and function as name tags for transport. They may also alter the polarity and
stability of the protein that they are attached to.
The linking itself can happen in two ways as shown in Figure 2.2. First, an O-
glycosidic link joins a carbohydrate to the hydroxyl group of a Ser or threonine (Thr)
residue. Second, an N -glycosidic link attaches a carbohydrate to the amide nitrogen
of an asparagine (Asn) residue. The latter linkage depends on a consensus sequence
of three amino acids where the first is the linking Asn, the second is anything else
but proline (Pro), and the third is either a Ser or Thr [26]. Still, not all of these
sequences combine with carbohydrates, and on the other hand exceptions to the
consensus sequence have also been reported [33].
The propensity of an Asn residue to be glycocylated depends on several fac-
tors [33]. On an atomistic level, the linkage is favorable when the hydroxyl group
of Ser/Thr forms a hydrogen bond to the carbonyl group of an Asn side chain,
decreasing the dissociation constant of the amide group, and thereby increasing
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Figure 2.2: (a) O-linked oligosaccharides form glycosidic bonds to the hydroxyl group of
Ser/Thr side-chains (red). The illustration shows N -acetylgalactosamine at the reducing
end of the sugar chain. (b) N -linked oligosaccharides connect to the amide nitrogen of an
Asn residue (green) with N -acetylglucosamine as the terminal sugar.
its affinity for the carbohydrate. Other elements influencing the formation of an
N -glycosidic linkage are dictated by the surrounding environment. For example, en-
zymes performing the concatenation are highly tissue specific. Furthermore, besides
the primary structure, also the tertiary structure around the consensus sequence
mediates the affinity for the carbohydrates. Lastly, but rather interestingly, the
tendency to be glycocylated seems to be reduced the closer the sequence is to the
C-terminal end of the protein.
The most common type of attached carbohydrate in mammalian glycoproteins is
the so called "core pentasaccharide" portrayed in Figure 2.3. Usually these kinds
of oligosaccharides are highly specific for a certain individual, like the carbohy-
drates defining our blood groups. However, the core pentasaccharide is neutral in
that respect, and thereby induces no immune response. On a structural level, the
reducing end of the pentasaccharide Man-α1 → 6(Man-α1 → 3)-Man-β1 → 4-
GlcNAc-β1 → 4-GlcNAc-β1 → or simply Man3GlcNAc2 attaches to the side chain
amide nitrogen of the Asn residue through an N -glycosidic linkage. Usually, the
distal mannoses are extended by the addition of other monosaccharides, such as
sialic acids, to their ends [33].
Just like proteins, also lipids can be conjugated with carbohydrates [26]. It is
usually the membrane sphingolipids whose head groups are replaced with oligosac-
charides like sialic acids. These glycolipids play an important role, for example, in
signal transduction. Consequently, the brains and neurons are often rich in these
conjugate lipids.
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Figure 2.3: Core pentasaccharide attached to an Asn residue of a protein and represented
with a ball-and-stick model using Visual Molecular Dynamics (VMD) software [35] and
Tachyon ray tracing library to render the image. Basic structure and common naming
conventions are illustrated with braces and arrows. Hydrogen atoms are colored gray,
oxygen atoms are red, and carbon atoms that belong to the sugar are green. For the sake
of clarity, protein carbons are colored cyan.
2.2 The Glycocalyx Houses a Wide Array of Biomolecules
Glycocalyx is an intricate, highly complex self assembling 3D network. In addition
to numerous polysaccharides and glycoconjugates, it also includes a large variety
of adsorbed components with no clear boundaries between those and the synthe-
sized ones [4]. Furthermore, in normal physiological conditions, the glycocalyx is
subjected to high turnover rates and thus experiences a dynamical balance between
carbohydrate synthesis and shedding-dependent alterations [1]. Due to this dynamic
and soft nature, the glycocalyx is extremely hard to define geometrically [21, 36].
In spite of this, many of the individual components are nowadays recognized and
characterized [4]. Their distribution and intermolecular interactions have, however,
remained largely unidentified, and if such data exists, it is only qualitative and often
indirect. Figure 2.4 depicts the complex structure of the glycocalyx with only a few
of the main components presented explicitly.
Overall, the glycocalyx contains five different GAG species, namely hyaluronic
acid (HA), chondroitin sulphate (CS), heparan sulphate (HS), dermatan sulphate
(DS), and keratan sulphate (KS) [4]. While HA is the most abundant GAG in
the glycocalyx forming its structural basis, the others are also highly important in
modulating and cross-linking the pericellular environment.
The glycocalyx connects to a plasma membrane via so-called backbone molecules,
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Figure 2.4: Schematic figure representing the main components of the glycocalyx. Re-
produced from ref. [37].
namely glycoproteins and proteoglycans. Generally, glycoproteins reside in special
cholesterol-rich lipid rafts, to which the caveolin-1 proteins also attach from the
cytosolic side of a plasma membrane in order to bend it and to form cave-like struc-
tures called caveoli [3]. For example, glycocylated adhesion proteins like integrins,
immunoglobulins, selectins, and isoforms of CD44 often concentrate on these rafts.
In addition, glycoproteins along with some proteoglycans connect the glycocalyx to
the cytoskeleton, and thereby enable the cell to sense the surrounding environment
and adapt mechanically to each change [3, 5].
Proteoglycans of the glycocalyx vary largely in their size, number of attached
GAGs, and their interactions with a plasma membrane. For instance, glypicans [38]
are anchored with a glycosylphosphatidylinositol (GPI) anchor, and syndecans [39]
are transmembrane proteins, while perlecan [40], mimecan, and biglycan [41] are
secreted. Interestingly, the GAG-ratios of these proteoglycans have been observed
to change not only according to intracellular, but also extracellular stimuli [42].
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Figure 2.5: The chemical structure of hyaluronic acid.
This highlights the dynamic nature of the glycocalyx constantly subjected to various
alternations and stimuli.
Despite their non-covalent attachment, the adsorbed components are an impor-
tant ingredient of the glycocalyx. Especially in the vascular endothelium, many
blood-borne proteins and soluble proteoglycans, along with cations of all sorts, ad-
here to the surface of the cells [3, 4]. As a result, they sustain the charge-selectivity
within the thick network of negatively charged sugars. Moreover, the soluble com-
ponents are suspected to function as cross-linkers for GAGs, such as the HA.
2.3 Hyaluronan is the Primary Component of the Glycocalyx
Hyaluronan or hyaluronic acid is a linear, multifunctional, and highly anionic GAG
forming the basis of both glycocalyx and ECM [2, 7, 25, 43]. It contains alternating
N -acetyl-d-glucosamine (GlcNAc) and d-glucuronic acid (GlcUA) residues linked
to each other via a β(1 → 4)-glycosidic linkage, while the dimers attach to each
other through β(1 → 3) bonds. HA is also extremely abundant in most tissues of
the human body. For instance, synovial fluid and vitreous humour contain high
concentrations of this polymer, because it acts as a lubricant and gives these fluids
their jelly-like consistency. Furthermore, the name hyaluronic acid itself was derived
from this glassy and translucent appearance, as the Greek word "hyalos" refers to
glass [26]. Figure 2.5 presents the chemical structure of one HA dimer unit.
HA was first purified in 1934 and its chemical structure was solved twenty years
later [25]. At first, it was thought to serve as merely a lubricant and structural
scaffold, yet later HA has been shown to play a role at least in adhesion, migration,
and proliferation of various cell types, along with water homeostasis, filtering, ex-
clusion, scavenging of free radicals, and mediating the angiogenesis in most of the
mammalian tissues [44]. Moreover, currently HA is widely employed in the cosmetic
industry [45] and has also been recently utilized in various biomaterial applications
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serving as tissue engineering scaffolds [46] or drug delivery devices [47].
Compared to other GAGs, HA shows some unique physical properties. For exam-
ple, it is regarded as the longest molecule of the human body with molecular weights
up to 6-7 ×106 Da [48]. This weight covers a remarkable 2000 to 2500 disaccharide
units and spans polymer lengths of 2-25 µm [7]. The incredible magnitude com-
bined with the highly negative charge density originating from the carbonyl groups
in uronic acids gives HA its unique rheological properties, such as dynamic viscosity
and elasticity varying with concentration, molecular weight, and experienced shear
forces. Furthermore, the high flexibility of the HA polymer renders it an excellent
space-filling molecule, cramming voids in tissues or even acting like a molecular
spring.
In addition to being much longer and having different chemical structure, HA
differs from other GAGs in the way it is synthesized. That is, unlike other GAGs,
HA is assembled on the cytosolic side of a plasma membrane by proteins called
HA synthases (HAS). Instead of being modified afterwards, HA chain is extruded
straight to the extracellular space or retained at the glycocalyx. However, distinct
modification patterns arise from polymers of various lengths as they have been
shown to induce different physiological responses [49]. Indeed, HA is synthesized
and released in pieces of over 2 × 106 Da [50, 51], while the smaller fragments
with less than 20 carbohydrate monomers result from trauma or, by contrast, form
through hyaluronidase enzymes cleaving the longer HA polymers [52]. Interestingly,
high molecular weight polymers of HA seem to inhibit the formation of capillaries,
whereas the much shorter fragments induce it [49]. Another study showing only
the short fragments to inhibit the formation of glycocalyx in human aortic smooth
muscle cells in vitro [53] further highlights the discrepancy between the different-
sized HA polymers.
Still, one additional aspect separates HA from other GAGs – the binding to pro-
teins. While GAGs usually link to proteins covalently, HA is bound non-covalently
by a range of receptors commonly referred to as hyaladherins. They almost always
contain the HA-binding Link module, which is a disulphide-linked domain of around
100 amino acids acting as the hallmark of a protein family called the Link module
superfamily [25]. This name refers to a cartilage link protein involved in the forma-
tion of aggregate [54] structures, in which the HA chain forms the basis to which
proteoglycans called aggrecans attach via the link protein in a brush-like fashion.
Other members of this superfamily include laylin [55], LYVE-1 [56], and stabilin-
1 [57]. Yet, the primary receptor for HA is the cell-surface protein CD44 [58]. In
addition to these, HA is bound by proteins lacking the Link module, namely by
RHAMM (Receptor for Hyaluronan-Mediated Motility) [59], which despite having
no homology to other HA-binders, is able to compensate the function of CD44 in
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Table 2.1: A list of common hyaladherins and their locations inside human tissues.
Hyaladherin Description Ref.
CD44 Glycocalyx [58]
RHAMM Glycocalyx [59]
LYVE-1 Glycocalyx [56]
Cartilage link protein ECM [60]
Aggrecan ECM [54]
Versican ECM [53]
Neurocan ECM [61]
Brevican ECM [62]
TSG-6 ECM [63]
cdc37 Intracellular [64]
P32 Intracellular [65]
CD44-knockout mice. Lastly, HA polymers also sometimes retain at the cell surface
through their interactions with the HA synthases. In conclusion, many elements
that affect HA metabolism have been identified, yet similarly to the glycocalyx, the
molecular level details are still largely unknown. Table 2.1 summarises the main
HA-binding proteins.
Depending on the surrounding environment and the available stimuli, HA may
assume various configurations, as illustrated in Figure 2.6. For example, in the ECM
it forms highly cross-linked meshworks interacting with other ECM components,
such as collagen. These meshworks are stabilized by HA cross-linkers like TSG-6
(35 kDa secreted product of the tumor necrosis factor stimulated gene-6) [63, 66],
yet another protein with the Link module. In contrast to cross-linked networks,
cells also produce long cable-like HA structures [67–69] that seem to appear only
under specific stimuli, such as stress in the endoplasmic reticulum, viral infection,
or inflammation.
2.4 Hyaluronan Dictates the Functions of the Glycocalyx
The function of the glycocalyx is largely governed by the behaviour of HA retained
at the cell surface. In practice, these functions include acting as a permeability bar-
rier, facilitating leukocyte rolling upon inflammation, scavenging free radicals, and
transducing mechanical cues from the environment to cellular signals. Traditional
ways to study this HA-rich layer entail methods such as atomic force microscopy [70],
electron microscopy [71], optical traps [72], and particle exclusion assays [2]. The
latter refers to a procedure where a suspension of fixed erythrocytes is allowed to
settle, and subsequently a clear zone surrounding the sample cells is made visible
because of exclusion of the red blood cells by the HA coat. As a hyaluronidase
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Figure 2.6: Schematic illustration of intra-, peri-, and extracellular hyaluronan surround-
ing a cell like a chondrocyte.
treatment removes the optically clear zone, the integrity of glycocalyx is indeed
confirmed to be HA-dependent.
Owing to the extremely high density of HA meshworks, the glycocalyx is an
excellent permeability barrier, gating all the molecules trying to enter or leave the
cell. Behaviour like this is especially important in the vascular endothelium where
the absorption needs to be strictly controlled [73]. Indeed, blood hematocrit, the
volume percentage of red blood cells in the blood, experiences a two-fold rise when
capillaries are treated with hyaluronidase [74], thereby indicating the presence of
a thick glycocalyx. Consequently, the endothelial permeability for high molecular
weight molecules is far less than that for smaller ones [75]. Besides steric hindrance,
also charge plays a role when molecules try to pass through the cell coat. For
instance, neutralization of the glycocalyx with salt solutions in rat mesenteric small
arteries increases the intake of 50 kDa dextrans by a factor of two [76]. Due to its
charge and the osmotic forces, the glycocalyx is also an important regulator of water
homeostasis, creating an effective barrier for water and thereby guiding fluid flows
in tissues and protecting them from edema [3]. A recent study in fact shows that a
fixed polysaccharide network orders water and offers marked resistance to the bulk
flow of solvent [77]. In the light of this, it is no surprise that treating capillaries
with hyaluronidase increases the blood hematocrit so significantly.
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In addition to repulsion, the glycocalyx exhibits adhesive properties as well. It
has been implicated to play a central role, for instance, in leukocyte rolling. This
refers to a process related to inflammation where white blood cells, also known as
leukocytes, roll on the surface of the endothelium, thus creating right circumstances
to enter the underlying tissue [78, 79]. This blood-to-tissue transition is, in turn,
called extravasation. Traditionally, adhesiveness is correlated to integrin molecules
at the surface of the leukocytes and the endothelium [80, 81]. The role of HA-rich
glycocalyx has only recently begun to be unravelled [4], and interestingly, it seems
to possess a dual capacity in the recruitment of white blood cells.
On one hand, the glycocalyx promotes adhesion. Being a rather loose structure it
may allow the membrane extrusions of the leukocytes, where the adhesion molecules
usually reside, to reach the plasma membrane relatively easily. Furthermore, the gly-
cocalyx is known to mediate the early long-range interactions with the surfaces of
tissue culture substrates, before a firm integrin-mediated adhesion commences [82].
Similarly, the cable-shaped HA structures are clearly pro-adhesive, promoting ad-
hesion of white blood cells both in vitro and in vivo [68, 83]. Indeed, they seem
to possess unique leukocyte-binding properties and may potentially influence the
clustering of HA-receptors on the surface of white blood cells [67].
On the other hand, the glycocalyx dampens the leukocyte adhesion. Steric hin-
drance seems to play an integral role since most adhesion molecules are much shorter
than the thickness of the glycocalyx [84, 85]. Furthermore, HA is though to be an
antiadhesive lubricant promoting cell rounding and detachment. Supporting this
hypothesis, a decreased synthesis of HA due to an HAS antisense RNA is found
to reduce the migration of keratinocytes [86]. Further supporting the anti-adhesive
character is the fact that highly flattened and spread cells, like the smooth muscle
cells, produce very little or no glycocalyx [2]. When both the cell and the substrate
express HA, no attachment takes place, but when only other one has it, the con-
nection is established [2]. Overall, adhesiveness seems to depend on reasons such
as local concentration, cross-linking, synthesis rate, and degradation of HA, while
at the same time being regulated by factors like size, amount, cellular location, and
malleability of this long polymer.
Yet another matter affecting leukocyte rolling and attachment is the shedding of
the glycocalyx. In other words, certain chemical and mechanical cues are observed
to shed the HA chains of the glycocalyx, so that the synthesis of GAGs and the
shedding exist in a dynamic balance [78]. This behaviour is also believed to be an
important mediator in inflammatory response [87]. In practice, free radicals and
various chemoattractants released by inflammation would activate matrix metallo-
proteinases, zinc-containing proteolytic enzymes that degradate components of the
ECM. These enzymes would in turn facilitate the shedding of the glycocalyx. Sub-
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sequently, leukocytes in blood would get an easy access to the plasma membrane of
the endothelium [1]. This could, as such, imply that the glycocalyx acts as a barrier
for white blood cells in uninflamed tissues, denying their access to healthy parts of
the body. However, inflammation is not the only stimulus to which the cell coat is
known to react to. Shedding can, indeed, be facilitated by a range of factors such as
hyperglycemia [88], septic shock [89], presence of oxidized LDL [90], ischemia [91],
high blood shear stress [92], many biochemical agents [93], and free radicals [94].
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3. CD44 IS THE PRIMARY RECEPTOR FOR
HYALURONIC ACID
CD44 is a highly abundant molecule in our bodies. It is present in most cell types,
but is especially plentiful in leukocytes, fibroblasts, endothelial cells, white matter
of the brain, and smooth muscle cells [6]. In addition to these normal cell types,
CD44 is encountered in a range of cancers [11, 12, 95–97]. It was first described
as brain-granulocyte-T-lymphocyte antigen [98]. After its discovery, at the early
1980s, it has been referred to with several structural and functional names, such
as GP90Hermes, ECM receptor II, hyaluronate receptor, phagocyte glycoprotein-1,
homing cell adhesion molecule, glycoprotein i5, Ly24, and HUTCH-1. However,
when it was cloned for the first time at the late 1980s, the name CD44 was estab-
lished [6]. A following sequence comparison revealed over 50 % homology with the
cartilage link protein, thereby suggesting that CD44 might also be an HA binding
protein. In 1991, a rat pancreatic tumor cell line was induced to metastasize by the
transfection of complementary DNA (cDNA) encoding a specific CD44 isoform [99],
and after this surprising discovery CD44 has been an interesting target for a range
of pathological and biochemical studies that have thus far implicated it to play a
crucial role in both cancer progression and cellular motility.
This chapter presents the latest knowledge on CD44 structure and functions, with
a focus on its interactions with HA. The chapter is divided into four sections that
each describe a different part of the CD44 biology. The first section gives a solid
overview of the CD44 structure and its genomic organization. The second chapter
then presents the main physiological implications of the CD44-HA interactions, thus
helping the reader to understand the biological importance of this molecular-level
event. Next, the third section summarizes a complex, yet important, aspect of
native CD44 function, the regulation of HA binding. The chapter then concludes by
a review of the relevant structural and computational studies previously conducted
on CD44.
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Figure 3.1: Exon map of the CD44 genome. The left column gives the names of the cor-
responding isoforms, while the right column specifies the cell or tissue where it is normally
found.
3.1 CD44 is a Membrane Protein with Functionally Distinct
Domains
CD44 is a transmembrane glycoprotein. It is coded by a single gene that is, however,
subjected to extensive alternative splicing, enabling the cell to generate multiple
unique isoforms of the protein. In humans this gene is located at the short arm of
chromosome 11 [100] and covers roughly 50 kb of genomic data [101]. In mice it
contains 20 exons [102] from which the first five are constant and thus, termed as
the 5’ constant region. By contrast, the next 10 exons are subjected to alternative
splicing and thereby create a so-called variable region, designated as exons v1–v10
or simply as exons 6–15 in the sequential scale. The last five exons in the gene are
called the 3’ constant region, while the final exons, 19 and 20, are again alternatively
spliced [102]. Importantly, human CD44 has only 19 exons [101] because the v1 tract
does not exist. The naming of the gene, however, still follows the same convention as
with the mouse gene, so that in humans v2 is the first variably spliced exon (Figure
3.1). It should also be noted that this study focuses only on the human CD44, albeit
it has 88 % sequence homology with the mouse protein.
Given the large variety of possible exon combinations, CD44 occurs in various
isoforms [103–105]. The most common of these is the standard CD44, abbreviated
as CD44S or CD44H because it is especially abundant in hematopoietic cells [106].
This standard form has no variable exons, so the 5’ region is directly attached
to the 3’ region. After the cleavage of the N-terminal 20 amino acid long signal
peptide, CD44S translates into a 341 amino acid long protein with a predicted
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Figure 3.2: Schematic figure representing the different domains and posttranslational
modification sites of a membrane-bound CD44.
molecular weight of 31–38 kDa [6]. The observed molecular weights are, however,
around 85–95 kDa. This apparent discrepancy can be explained by the insertion of
extensive posttranslational modifications like glycosylation, GAG attachment, and
phosphorylation from which the last takes place only in the cytoplasmic parts of the
protein, while the first two modify the extracellular part of the protein [6].
CD44 structure can be divided into three main parts: extracellular region, trans-
membrane segment, and cytoplasmic tail. The first is further divided into an N-
terminal HA binding domain (HABD) and to a stalk-like stem region that connects
the HABD to the transmembrane segment [15]. A schematic presentation of the
CD44 structure illustrating these structural principles is shown in Figure 3.2.
The 158-residue-long globular HABD [15] is encoded by the exons of the 5’ con-
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stant region [6]. It contains six cysteine residues stabilizing the globular fold by cre-
ating three intraprotein disulphide bridges [107]. As the name implies, the HABD
comprising the Link module (residues 32 to 123) enables the binding of the HA poly-
mers [15, 16, 108]. Importantly, HABD retains its ability to bind HA even when
expressed alone, without the rest of the protein [108]. This is a feature that has
made it possible to study the details of CD44 structure and function, even though
the whole transmembrane protein has been difficult to clone and crystallize.
The stem part is coded by the first two exons of the 3’ constant region. Apart
from linking the HABD to the transmembrane segment, very little is known of
its structure. It is, however, known to contain multiple O-glycosylation and GAG
insertion sequences, and therefore to be heavily glycosylated in its native state [10].
The stem also contains sites for proteolytic cleavage [109, 110], a process that might
be vital for cell motility, as it can rapidly terminate the adhesion interactions. Most
importantly though, the stem is the structure to which the alternatively spliced parts
are inserted in variant isoforms [111]. In principle, over 800 different membrane-
bound CD44 isoforms could be generated [6, 8], but because the trancription process
is highly regulated by mitogenic signals not all of them are encountered in real life
cell populations. Notably, the variant exons introduce additional glycosylation sites
to the stem of the protein. Along with ordinary N and O-glycosylation sites some
of the variant parts, like v3 and v6 exon products, contain specific Ser-Gly-Ser-Gly
motifs for the incorporation of HS and other GAGs [107, 112–115].
After the extracellular parts, the next 21 amino acids (residues 269-290) coded
by exon 18 constitute the short transmembrane segment. It contains one cysteine
residue having the ability to form disulphide bridges, and it is therefore believed to
be involved in CD44 oligomerisation [116], yet another factor regulating CD44 func-
tion [6]. The transmembrane segment is also thought to be responsible for locating
CD44 into specific lipid rafts called glycolipid enriched microdomains (GEMs) [117].
This GEM-association varies according to cell type, but is regarded as a crucial as-
pect in CD44-mediated signal transduction, as GEMs harbor most of the signaling
molecules that associate with the cytoplasmic tail of CD44.
The cytoplasmic tail region can be coded by either exon 19 or 20. As a result,
the length of the tail is either 3 or 72 amino acids, respectively [6]. The long tail is,
however, more common and it contains binding sites for many intracellular adaptor
molecules along with six conserved phosphorylation sites [118]. This is also the
part considered to be responsible for the subcellular localization, and mediating the
clustering of CD44 through interactions with the cytoskeleton [6].
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3.2 Ligand Binding Induces CD44-Mediated Signaling and
Adhesion
CD44 functions can be divided into at least three specific categories: a platform
for enzymes and substrates, a co-receptor for signal-transducing molecules, and a
simple structural adhesion molecule [8]. Unlike the others, the first function is
not strictly dependent on HA binding. That is, when residing in the glycocalyx
CD44 acts as a platform to growth factors and enzymes, thereby increasing the
capacity of these molecules to interact with their own ligands, and thus lowering the
threshold for cellular signal tranduction [119]. In addition to HA, CD44 has been
known to have also other, secondary ligands like osteopontin and mucosal vascular
adressin [120–122]. The biological relevance of these interactions is not clear, but
these molecules seem to have binding sites especially in the variant region and have
also been implicated in cancer or prolonged inflammation [123].
The second main function means, in essence, that the CD44-HA binding activates
several intracellular signaling pathways leading to changes in cell motility, shape, and
survival [6, 8]. Instead of possessing an intrinsic catalytic activity, the CD44 tail
region affiliates with several adaptor molecules with the ability to initiate migration
and cell survival-related signaling pathways [124–128]. For instance, Src family of
receptor tyrosine kinases (RTKs) is constitutively associated with CD44, activating
a Ras signaling pathway trough protein kinase C (PKC) [129], thus upregulating
genes that promote cellular migration and invasiveness [130]. Further fortifying
the role of CD44 in cancer progression, PKC also upregulates downstream factors
inhibiting apoptosis, the process of programmed cell death, and altering the body’s
drug resistance [12, 131]. In fact, most of CD44 adaptor molecules seem to be related
to cancer progression by controlling these vital cellular processes.
A group of transmembrane RTKs called the ERBB protein family is often ex-
pressed in various tumor cell types. Interestingly, at least two studies have demon-
strated CD44 to form heterodimers with these proteins, especially with ERBB2,
and that this interplay is highly dependent on CD44’s interaction with HA poly-
mers [127, 132]. The CD44-ERBB2 complex indirectly activates the Ras signaling
cascade [127] through a chain of secondary adaptor molecules associating with it on
the cytoplasmic side of the a membrane, as shown in Figure 3.3.
Band 4.1 superfamily proteins, such as one called ERM [133], are yet another
class of CD44 partner proteins utilizing the common Ras pathway. In addition to
activating the growth permitting state in a cell cycle, the active ERM enhances the
incorporation of variant exons to CD44s being assembled at the ER [134]. However,
there is normally a delicate balance between ERM and its antagonist called Merlin,
which acts as a competitive inhibitor for ERM when binding the cytoplasmic tail of
3. CD44 is the Primary Receptor for Hyaluronic Acid 22
+/- +/- - -
HA short HA SolubleCD44
Anti-CD44
mAb
ERM
src
PKC
Shc
P
mSOSGrb2
Raf
Ras
MEK
MAPK
Myc
Erk1
PKCξGTP
IKK2
IKK1
NFκBlκBα
lκBα
P
NFκB
P
Ankyrin
RhoA Tiam1
Rac
P
P
No signaling
Nucleus
Invasiveness
Proliferation
Migration Cytoskeletalchanges
Tailless
CD44 CD44Erb2
Cytoskeleton
Figure 3.3: CD44 induced signaling (reproduced from Ref. [25]). The signals are trans-
mitted through accessory molecules that activate several signalling cascades that in turn
active nuclear transcription factors or other effector molecules. Most of the observable
down-stream effects relate to migration and cell shape changes. Anti-CD44 mAbs and
soluble CD44 HABDs can inhibit the signaling, whereas the size of HA can have either
positive or negative effect.
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CD44 [135]. Which one of the two is more powerful depends on the ruling cellular
conditions. For instance, mitogenic treatment seems to favor growth, while a high
cell density together with the presence of high molecular weight HA inhibits growth
by activating Merlin [135]. This behavior is at the same time an intriguing example
of the effect of HA size on CD44-mediated cell signaling.
Some CD44 adaptor molecules, including ERM, also directly cross-link CD44
to the cytoskeleton. These interactions then lead to rapid reorganizations of the
actin cytoskeleton causing the formation of membrane protrusions, such as lamel-
lipodia [128]. For example, T-lymphoma invasion and metastasis inducing protein 1
(Tiam1) promotes cytoskeletal reorganization through Rac1 GTPase enzyme [125]
and a protein called Ankyrin links CD44 to cytoskeleton after activation by a CD44-
bound Rho kinase [136, 137]. Interestingly, Ankyrin only accumulates underneath
CD44 upon its binding to HA [138], again displaying the vital role of HA in the
CD44-mediated functions.
Remarkably, the CD44-mediated signaling seems to be totally dependent on the
interaction with HA. Whether this is due to accumulation of CD44 or some other
reason, it can be readily demonstrated by disrupting the constitutive CD44-HA
interactions using three different methods. First, the utilization of exogenic HA
oligomers has been effective in displacing the polymeric high-affinity HA [139]. Sec-
ond, soluble CD44 HABDs competitively bind to HA, and thereby hinder the native
CD44-HA interactions [140, 141]. Third, CD44-specific siRNAs or mAbs are able to
block the binding of HA by disrupting the translation of the protein or by compet-
ing for the same binding sites, respectively [6]. Applying these methods will result
in an attenuation of the CD44-associated cell signaling [95, 142] and, for example,
dissociation of the complex between CD44 and ERBB2 [127]. Although, it must
be noticed that the size of HA may also play a significant role in determining the
level, and even the malignancy, of the CD44-dependent signaling. In one occasion,
for instance, shorter fragments (≤ 267 kDa) were able to activate the nuclear tran-
scription factor NFκβ in several human cell lines, while the longer, high molecular
weight, polymers had an inhibitory effect on the same process [143].
In addition to platform and co-receptor roles, CD44 can be considered simply
as a ligand-binding protein facilitating cell traffic through reversible interactions.
Indeed, cellular migration is most prominent in HA-rich spaces, such as in wounds
undergoing repair, in inflamed tissues, or in close proximity to tumor cell mass [8, 12].
The dependency of these processes on the CD44-HA interactions may again be
evidenced by blocking the cell movement with CD44-specific mAbs, soluble HA,
or treatment with hyaluronidase [144]. Furthermore, the interplay between CD44
and HA ultimately gives leukocytes the ability to roll on endothelial surface in a
velcro-like fashion, creating suitable circumstances for successful extravasation [145]
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Figure 3.4: CD44 in leukocyte extravasation. Leukocytes in the blood stream adhere
to the endothelium surface where the CD44-HA interplay takes care of the initial rolling
interactions before strong integrin-mediated adhesion.
(Figure 3.4). Not surprisingly, it is also the same mechanism that is exploited by
tumor cells metastasizing to secondary sites through blood or lymph circulation [12].
3.3 CD44 is Subjected to Multiple Levels of Regulation
Every CD44 expressing cells does not bind HA. This status may, however, alter very
rapidly in response to changes in the surrounding conditions or intracellular stimuli.
The dynamic switching of binding affinity is undoubtedly crucial for cells migrating
through HA-rich matrices and for the steps of HA-dependent leukocyte rolling. Yet,
no single mechanism controlling this behavior can be pointed out [8]. Instead,
given the importance of the CD44-HA interaction, several levels of regulation are
probably needed for the normal function. The binding of HA to CD44 is, indeed,
collectively affected by at least factors like glycosylation [10, 16, 146], expression of
variant exons [147, 148], conformational changes [16–19], cleavage of the cell surface
CD44s [109, 110], clustering of CD44s [149], differential orientation of the CD44s at
the cell surface [149], internalization of the HA polymers [150], and variations in the
HA chain length [14, 149]. However, the relative contribution of these non-mutually
exclusive mechanisms is currently unknown. Figure 3.5 summarizes the different
factors having the ability to regulate the CD44-HA interactions.
One of the simplest way to regulate HA-binding is to recognize various sizes of
HA fragments. CD44 has been shown to coordinate a minimum of six HA residues,
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Figure 3.5: Factors that can regulate CD44-HA interactions.
or three disaccharide repeats, yet only after eight carbohydrate residues HA covers
the full length of the binding site [14]. Whether these differences in binding affinity
bear any physiological relevance is currently unknown. However, the evidence shows
at least that low molecular weight HA (20–500 kDa) promotes cell cycle progression,
while higher molecular weight fragments (≥ 106 kDa) inhibit the same process, ren-
dering the cells quiescent and adhesive [44, 151]. Similarly, the shorter HA fragments
induce inflammation, whereas the longer polymers induce the completely opposite
state, immunosuppression. There is also some evidence of HA size being able to act
as a switch between adhesive and migratory functions [44, 152]. If that is the case,
the longer polymers and cable structures of HA are likely to induce the clustering of
CD44s on the cell surface, and thereby alter the collective status of the CD44-HA
interactions to favor signaling pathways inducing adhesion. Therefore, it is probable
that at least some of the regulatory potential lies in the spatial arrangement and
in the clustering of CD44, backed by the recent findings by Wolny et al. [149], who
evaluated the effect of HA size and clustering on the CD44-HA interaction.
Wolny et al. [149] investigated two model systems: monomeric CD44 HABD and
dimeric HABD. In both cases the CD44 HABD was fused with an immunoglobulin
Fc domain and attached to an artificial membrane system. They found the binding
of HA to increase in a sigmoidal fashion as a function of HA size, with a plateau after
262 kDa. The reversibility of the binding was also strongly dependent on HA size.
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More precisely, when the molecular weight of the HA oligomers was below 10 kDa,
the binding was reversible and highly dependent on HA concentration, whereas at
molecular weights of over 30 kDa the binding was totally irreversible. This can be ex-
plained by the long HA chain having multiple "binding sites" for CD44s collectively
rendering the adsorption irreversible. Interestingly, upon analyzing the packing of
CD44 on the membrane surface they discovered the mean distance between individ-
ual HABDs to be twice as much as the peptide core of the protein. The authors
therefore speculated that native glycosylation of the CD44 HABD might limit the
packing of the proteins.
Undoubtedly, glycosylation plays a role in regulating the binding of an HA poly-
mer to CD44 HABD. Supporting this claim, three different activity states for CD44
have been discovered from normal cell populations [9]. The first one is a constitu-
tively active form constantly interacting with the HA polymers. The second form
is inducible, so that unless activated by specific antibodies or cytokines, it does not
bind to HA. The third form is constitutively inactive and cannot be activated even
with the aforementioned factors. As the molecular weights of each of these forms
were characterized with immunoprecipitation before and after deglycosylation, the
inactive form was clearly the heaviest before the treatment, followed by the inducible
form, and leaving the active form as the lightest. These differences were assigned
specifically to different N -glycosylation patterns of CD44 HABD. In another study,
inactive cells acquired the ability to bind HA after treatment with neuramidase, an
enzyme cleaving off terminal sialic acids from the attached carbohydrates [153]. The
concentration of CD44 remained unchanged through the experiment, implying that
these qualitative changes might be more important for HA binding than the actual
expression levels of the protein.
When regulating the CD44’s binding affinity the most prominent target for gly-
cosylation is, of course, HABD. It contains five N -glycosylation sites (Asn25, Asn57,
Asn100, Asn110, and Asn120) from which two (Asn25 and Asn120) have been shown,
through mutation experiments, to be especially sensitive to a glycosylation-induced
disruption of the native CD44-HA interactions [15]. That is, deglycosylation of these
residues has the ability to turn CD44 from an inducible to a constitutively active
form in murine lymphoma cell lines [10]. The exact mechanism through which gly-
cosylation mediates the CD44-HA interactions is unclear, but it can, in principle,
occur in several ways including steric hindrance, charge repulsion, induction of con-
formational changes, or inhibiting the clustering of CD44. Interestingly, treatment
with deoxyjirimycin, an antibiotic inhibiting the processing of N -linked glycans, did
not transform the CD44 phenotype from inactive to active [154]. While opposing
discoveries have also been made, the above finding could imply that alterations in
HA binding stem from differential utilization of N -glycosylation sites rather than
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Figure 3.6: Structure of the CD44 HABD. The figure on the left shows a newcartoon
representation of HABD colored according to the secondary structure. It also gives appro-
priate names for the secondary structure elements. The figure on the right shows a surface
representation of HABD, where some of the relevant binding site residues are marked with
arrows. The bound HA oligomer is colored cyan.
from the differential processing of the N -linked glycans. In another study, removal
of some of the terminal sialic acids from the attached sugars was enough to trans-
form CD44 from inactive to active [155], in turn implying that all the glycosylation
sites are not equally important, as even the active form can still have some of these
sites glycosylated.
3.4 Affinity for Carbohydrates Lies in the Hyaluronan Binding
Domain
To understand the details of HA binding one must first understand the structure of
CD44 HABD. The Link module is a highly conserved α/β-fold, with two antiparallel
β-sheets consisting of six β-strands and two α-helices [15, 16]. In CD44, it is enlarged
by so-called flanking N- and C-terminal sequences constituting four additional β-
strands. The interacting residues lie mostly in the shallow groove located on the
upper surface of CD44 as viewed in Figure 3.6. To shed light on the possible role
of each N -glycosylation site, and to map the whole HA binding region, a range of
structural studies have been performed over the last twenty years.
The earliest attempt to map the HA binding surface in CD44 involved sequencing
of the primary structure of CD44 HABD [13]. The goal was to find areas of basic
amino acids that would readily interact with the negatively charged hexuronate
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groups of HA. As a result, two clusters were identified. The first one lies in the
link homology region and involves amino acids 21 to 45. Importantly, supported
by a mutation-induced loss of binding ability, arginine41 (Arg41) was found to be
especially prominent in interacting with the HA oligomers. Later its role has been
confirmed in multiple occasions [14, 16–19], with methods ranging from site-directed
mutagenesis to computer simulations. The second cluster of basic amino acids, in-
volving the most C-terminal amino acids of HABD (residues 144–167), was located
outside the Link module. From these, Lys158 and Arg162 had the biggest contri-
bution in binding the ligand, which has, however, later been questioned by Banerji
et al. [16], who claim that the binding ability is conferred exclusively on the Link
module.
After the first experiments by Peach et al. [13], Bajorath et al. [14] conducted a
combined modeling and mutagenesis study to identify the precise residues partici-
pating in the HA binding. They built their model with homology modeling using
a solution structure of TSG-6 as a template, and based on this, 24 residues were
selected to be mutated. By comparing conservative and non-conservative muta-
tions the authors were then able to deduce if the residues were directly or indirectly
important for the binding of HA. For instance, amino acids Arg41, Tyr42, Arg78,
and Tyr79, brought together by the β1-α1 and α2-β3 loops, form an especially
important pincers adhering to the HA polymer and tying it firmly into place.
Teriete et al. [15] solved the first crystal structure of a non-glycosylated human
CD44 HABD. A comprehensive analysis of the structure verified many of the earlier
results obtained by Bajorath et al., including the role of most of the binding residues.
Furthermore, additional NMR studies suggested that the Link module was stabilized
upon HA binding, while the C-terminal flanking sequences of HABD were subjected
to a major conformational change unfolding the last residues of HABD. This is also
consistent with the NMR findings by Takeda et al. [19, 156, 157], who interpreted
the attained chemical shift patterns of C-terminal residues 152 to 169 to be a clear
indication of a rather large conformation transition from ordered (O) to a partially
disordered (PD) state. Encouraged by these findings, the same group conducted an
experimental in vitro assay where they observed a dynamic balance between O- and
PD-conformations, with PD being the higher affinity state [158]. Intriguingly, they
also proposed that the coexistence of these two conformations could in macroscopic
scale enable the leukocytes to roll in a velcro-like fashion. However, this idea has
not been verified by any experimental means.
Meanwhile, Banerji et al. [16] presented a crystal structure of mouse CD44 in
complex with an HA octamer in two different conformations. Interestingly though,
these two conformations were totally unrelated to the ones found by Teriete et al.
and Takeda et al. Instead of a huge relaxation of the C-terminus, these changes
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were related to the position of the Arg41 side-chain. The ligand was bound in both
conformations, but the so-called A-form had no apparent contact between HA and
the side-chain of Arg41. By contrast, in B-form the Arg41 containing loop was
tilted slightly to allow the side-chain to flip towards the bound HA and to establish
hydrogen bonds between each other. As the previous crystal structure without the
bound HA was in A-form, the authors suggested that the B-form corresponds to a
high affinity state.
Two MD studies then addressed the effect of these conformational transitions [17,
18]. First, Jamison et al. [17] identified the typical Arg41 side-chain rotamer popu-
lations and torsion angles of the Arg41-containing loop characteristic to the A- and
B-forms. As a conclusion the authors claimed that the otherwise unfavorable B-form
becomes highly favorable in the presence of an HA polymer. They also measured
the free energies of these two conformations to be roughly equal. A very recent
study by Favreau et al. [18], however, found the free energy of the B-form to be less
than that of the A-form’s. The authors therefore assigned the B-form to represent
the most favorable state in the presence of a bound ligand. They also measured the
free energy of A- and B-forms in both O- and PD-conformations and, surprisingly,
found no evidence of allostery between these two conformational changes. However,
they did propose structural evidence for the high affinity binding in the PD state.
That is, as conformational flexibility of the C-terminal tail in the PD conformation
is increased, Arg154 is, consistent with early finding by Peach et al., able to form
more favorable interactions with the bound HA oligomer.
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4. COMPUTATIONAL METHODS AND
SIMULATION PARAMETERS
Nowadays, computer simulations play a highly important role in science. Yet, in the
past, science was based on two corner stones: theory and experiment [22]. Theory
often expresses the problem in a form of a mathematical equation. This kind of
approach is, however, reasonable only for a limited number of simplified cases where
the mathematical formulation yields a strict analytical solution. Today, theories are
more often based on the dynamics of a vast number of particles, and deriving exact
analytical solutions to such systems is impossible without a considerable amount of
simplification.
Similarly, with experiments one has to handle large sets of research data gathered
from different measurements. This data is then fitted to an existing theory or
sometimes novel features are discovered through generalization and imagination.
Still, the complexity of the results is often overwhelming and analytical solutions
that fit the measurement data are difficult to find [159]. Furthermore, experiments
are still rather limited in their resolution. In other words, nanoscale phenomena,
like the interactions between biomolecules, are too rapid or tiny to be measured
accurately with experiments.
As computers have become more common and sufficiently powerful, they have
become a prominent tool in scientific research [22]. In fact, today computer exper-
iments or simulations are being regarded as the third corner stone of science. The
models for computer simulations are still provided by experiments and theory, but
the calculations are executed numerically by a machine that is following a certain
simulation algorithm. As a result, the investigated systems can be more complex
and realistic. Indeed, simulations allow one to understand the experimental results
in detail even at the nanometer scale. In addition, simulations can be employed to
carry out experiments too hazardous or expensive to perform in a real world [159].
It is important to remember that the results from computer simulations are always
approximations and simplifications of nature. For this reason, these results are
eventually always confirmed with experimental studies with real life physical models.
Strangely enough, oversimplification is in fact a true advantage of computational
methods. By discarding some of the irrelevant information, systems under study
can be reduced to a level where one can actually understand the physical laws
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governing a given process. That is basically the fundamental idea of modeling.
This chapter introduces the basic concepts of molecular dynamics simulations.
First, it gives an overview of the topic. Then, in the first and second subsections, it
describes the principle of accounting for the chemical and physical bonds between
atoms, and discusses the fundamental idea behind performing these simulations.
The next subsection then addresses the fundamental approximations employed in
MD. The second section reviews the theory of obtaining free energies from MD
simulations. Lastly, this chapter is closed by describing the simulated systems and
listing all the simulation parameters.
4.1 Molecular Dynamics for Simulating Biomolecules
Molecular dynamics (MD) is a computational method employing classical Newtonian
mechanics to model the time evolution of a given group of objects [160]. MD enables
the simulation of discrete particles as small as individual atoms. Thus, it is a
perfect method for studying biological molecules and their dynamic behavior with
atomistic precision. MD is able to predict equilibrium properties of a classical many-
body system. The term ’classical’ means that electronic degrees of freedom are
neglected in MD, and thus the motions of the nuclei obey the laws of classical
mechanics [161]. In other words, some accuracy is discarded at the expense of
reaching large enough time scales. Examples of phenomena studied with MD include
the permeation of drug molecules through lipid membranes [162], the collective
motions of lipids in a membrane [163], and the complex interplay between lipids and
protein molecules [164].
The simulated systems under study always comprise just a fraction of the whole
cell or a cell membrane. This is because larger ones would be impossible to study
with the current computer resources. However, the model systems still consist of
up to several million atoms, and simulating them requires a great deal of time and
computational resources. Therefore, large supercomputers and computer clusters
are often employed in order to reduce the required wall-clock time and to reach
the desired level of statistical accuracy. On the other hand, by simplifying the
systems it should be possible to achieve longer simulation time scales, but then
some microlevel phenomena might go undetected. Indeed, simulating biological
systems through model studies requires one to balance the available resources and
the desired accuracy of the results. At the same time it is worthwhile to realize that
an artificial physical model may produce misleading results even in the absence of
any computational limitations.
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Figure 4.1: A schematic illustration of a molecule and its internal degrees of freedom in
MD. The bond stretching motion l is depicted as the relative movement between atoms A
and B. Dihedral angle rotation φ is the angle between planes formed by atoms ABC and
BCD, while θ marks the bending of the angle formed by atoms CDE.
4.1.1 Force Field Describes Molecular Interactions
To understand the principle of MD one has to first consider intra- and intermolecular
interactions [161]. In classical MD the electronic distribution is approximated into
the form of an analytical potential energy function also known as the Hamiltonian
operator Htotal. It describes all the molecular interactions classically, by dividing
them into two categories, bonded interactions and non-bonded interactions:
Htotal = Hbonded +Hnon−bonded. (4.1)
Bonded interactions of a molecule refer to the internal degrees of freedom or
simply to the relative motion of the constituent chemical bonds. They comprise
bond stretching, angle bending, and dihedral rotation which are all further clarified
in Figure 4.1. Bonded interactions are taken into account with a generic potential
energy term of the following form:
Hbonded =
∑
bonds
1
2
kl,ij(lij − lij, eq)2 +
∑
angles
1
2
kθ,ijk(θijk − θijk, eq)2+
∑
dihedrals
Vn
2
[1 + cos(nφijkl − φijkl, eq)],
(4.2)
where the terms describe bond stretching, angle bending, and dihedral angle ro-
tation, respectively. Parameters kl,ij and kθ,ijk are the force constants for bond
stretching and angle bending, while lij and lij, eq represent the bond length between
atoms i and j and its corresponding equilibrium value. Similarly, values θijk and
θijk, eq describe the angle between atoms i, j, and k, and its equilibrium value. Di-
hedrals are expressed with a Fourier cosine series where n is the periodicity, Vn is
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the corresponding Fourier component, and φijkl is the dihedral angle along with its
equilibrium position φijkl, eq. Values for k’s are usually markedly high, so that bonds
will not overstretch unnaturally but rather stay at realistic conformations.
In MD, all non-bonded interactions are described with pairwise additive poten-
tials. In practice, the non-bonded Hamiltonian contains three terms
Hnon−bonded =
N∑
i=1
N∑
j=i+1
(
4ij
(σ12ij
r12ij
− σ
6
ij
r6ij
)
+
qiqj
4piε0εrrij
)
fij, (4.3)
which describe short-range steric repulsion, van der Waals interactions, and long-
range Coulombic interactions, respectively. The first two interactions are combined
into the Lennard-Jones potential, where the ij parameter is related to the energy
scale of the interaction describing the depth of the potential well. Meanwhile, σij
is related to the length scale of the interaction and is therefore called the van der
Waals distance. Parameter rij denotes the distance between interacting atoms i and
j. Strangely enough, the exponent of the repulsive term has no physical justification,
but is chosen only for the sake of computational efficiency as it is calculated just
by squaring the attractive term. Yet, it performs desirably well in describing the
interaction.
While the Lennard-Jones potential applies to all the particles in the system,
Coulombic interaction is calculated only between those particles i and j that bear a
charge qi and qj, respectively. The magnitude of these charged interactions depend
on the surrounding media according to ε0 and εr that describe the permittivity of
vacuum and the relative permittivity of the surrounding solvent, respectively. Im-
portantly, both Lennard-Jones and Coulombic interactions are scaled with a scaling
factor fij, so that fij = 0 for atoms that are less than three bonds apart in the same
molecule. In comparison, the scaling factor gets a value of 0.5 when the atoms are
exactly three bonds apart from each other, and a value of 1.0 in all the other cases.
In addition to the functional form, another important aspect in describing the
molecular interactions is the parameterization of the potentials. However, there is
no systematic way to parameterize these functions. Because of the relatively simple
form of the interaction potentials, each particle type requires different arguments.
Usually parameterization is conducted by comparing simulation results with ab initio
quantum-mechanical calculations or with experiments. Unfortunately, the various
parameters between different atoms are often interdependent, and therefore finding
a functional and reliable combination requires continuous iteration.
Together, the potential function and its parameterization are called the force
field. Despite its name the forces acting on each particle can be extracted only after
differentiating the potential function. Today, there are several force fields for the
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use of MD with a slightly different parameterization in each, and none of them is
able to describe all the physical properties of every atom type. However, they are
continuously being refined and thus, several versions of the same force field often
exist [161].
In this Thesis, we employed a force field called AMBER [165]. Its name stands for
Assisted Model Building with Energy Refinement, and we used the refined version
called AMBER ff99SB-ILDN [166]. It is a commonly used force field that is espe-
cially good for describing proteins and nucleic acids, but it has also several different
parameter sets for other biomolecules. One that is particularly important for this
Thesis is the GLYCAM parameter set [167] for simulating carbohydrates such as
GAGs.
4.1.2 Simulation Trajectory Evolves Through Numerical In-
tegration
The MD algorithm itself is rather straightforward. A simplified depiction of it is
presented in Figure 4.2. Importantly, this sequence of events is essentially the same
regardless of what simulation platform is being applied. For example, in this Thesis
we employ the GROMACS [161, 168, 169] simulation package, which is an open-
source software package supporting several different force fields.
To start an MD simulation one needs to construct topologies for all the con-
stituent particles. They define the constant force field parameters and the structure
of each atom type. Next, one must choose a correct statistical ensemble, such as
constant volume or constant pressure, which usually reflects the appropriate con-
ditions in related experiments. Before initiating the simulation, one still needs to
define the timescale it will cover and how frequently it will be updated. Today, typ-
ical timescales reach up to several microseconds while the interval of one simulation
time step is usually only a few femtoseconds. The initial structure of the system is
finally built by inserting the desired particles along with solvent molecules and ions
into a simulation box. This box can adopt multiple shapes, but the square is by far
the most practical due to its simplicity.
After having defined the system, all the constituent particles are assigned initial
velocities [161]. These are in turn generated from the Maxwell-Boltzmann distribu-
tion that reads
p(vi) =
√
mi
2pikBT
exp
(
− miv
2
i
2kBT
)
, (4.4)
where kB is the Boltzmann constant, vi and mi are the speed and mass of the par-
ticle i, and T is the absolute temperature. Importantly, the starting configuration
is never in equilibrium. It must, however, be reasonably close to it, so the system
4. Computational Methods and Simulation Parameters 35
Integrate
the
equations
of motion:
d2ri
dt2
=
Fi
mi
Calculate
forces
from the
potential
function:
Fi = ∇Htotal
Has the
simulation
time
reached the
maximum?
’t = tmax?’
Evaluate
and store
physical
quantitites:
Energies,
forces...
Increase
the
simulated
time:
t ← t + ∆t
Update
positions
and
velocities:
ri ∧ vi ∀i
Output: System’s time
evolution
System trajectories
Input: Initial conditions
Structure Topology
Figure 4.2: Schematic illustration of the MD algorithm. Fi expresses the forces acting
on particle i, Htotal is the total potential function, ri and vi give the position and velocity
of particle i, respectively, and similarly mi describes the mass of particle i. Parameter t
states the current simulation time, ∆t is the timestep, and tmax tells the endpoint of the
simulation.
is able to find a stable state after a short energy minimization. In other words, a
specific minimization algorithm, like steepest descent or conjugate gradient, probes
the system’s potential energy surface by moving the constituent atoms slightly with
respect to their initial positions in zero temperature. This procedure ensures that
none of the particles is subjected to unnaturally high forces when the actual simu-
lation commences.
The basis of MD lies in the numerical integration of the equations of motion.
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Through this procedure the algorithm updates the position and velocity of each
particle at every timestep. However, to be able to solve the equations of motion, the
forces acting on each atom are first required. They are obtained at every simulation
step before the actual integration by taking the negative gradient of the potential
function with respect to distances and angles to other particles (Figure 4.2). Con-
sequently, the force calculation is by far the most computationally demanding part
of the MD algorithm.
Once the forces are finally derived, there are several implementations that can
perform the numerical integration. A particularly efficient one is called the leap-frog
algorithm [170]. As the name vaguely suggests, the algorithm calculates positions
and velocities in turns, so that at every half step the velocity is solved as
vi
(
t+
∆t
2
)
= vi
(
t− ∆t
2
)
+
Fi(t)
2mi
∆t, (4.5)
while the positions are solved at whole steps
ri(t+ ∆t) = ri(t) + vi
(
t+
∆t
2
)
∆t. (4.6)
Parameters vi and ri in Eqs. (4.5) and (4.6) denote the velocity and the position of
particle i, respectively. Parameter Fi(t) expresses the force acting on particle i at
time t, while t and ∆t are the actual simulation time and timestep, respectively.
By repeating this general sequence countless times the simulation algorithm grad-
ually produces the output trajectories describing the system’s evolution as a function
of time. Eventually, the desired properties, like the energetics related to ligand bind-
ing, can be extracted from these trajectories with a myriad of different analyzing
techniques.
4.1.3 Computational Shortcuts Save Time and Resources
As any computational simulation, also MD employs several shortcut schemes. These
approximations are intended to improve the simulation’s runtime behavior by reduc-
ing the number of required force calculations, and in some cases to render the system
in many ways more realistic. For example, MD employs cut-offs to keep the poten-
tial short-ranged, and thus to retain the force calculations at minimum. This means
that by truncating or shifting the potential, it will reach the value zero after a cer-
tain cut-off threshold distance rcut. Such a procedure is particularly suitable for van
der Waals interactions since they decay fast as a function of distance. All in all,
the cut-off scheme causes a small bias in the potential energy of the system, but in
turn reduces the computational complexity from O(N2) to O(N), where N is the
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Figure 4.3: On the left, a schematic figure representing the fundamental idea of periodic
boundary conditions in 2D. The unit cell along with the particle trajectories are copied
in all directions and if a particle tries to leave the cell it simply emerges back from the
opposite side. The parameter L is the size of an individual cell. On the right, a real unit
cell is given as a snapshot from real simulation, where the CD44 protein is placed at the
center of the simulation box. Water molecules are omitted from this figure for clarity.
number of particles in the system [31]. Here we stress that rcut is used for van der
Waals interactions, but typically not for other more long-ranged interactions (see
below).
As a consequence of the cut-off, it will suffice to calculate the forces only between
neighboring particles. Therefore, the simulation box is geometrically divided into
smaller cubic cells whose size is only slightly larger than the cut-off radius. Then
it will be sufficient to evaluate the forces between the particles in the neighboring
cells only. As a result, this neighbor list is updated at defined intervals.
Furthermore, to avoid unwanted surface effects, a scheme called periodic bound-
ary conditions is employed. This means that the simulation box is periodically
repeated in every direction, as illustrated in Figure 4.3. If a particle leaves the unit
cell through the left border, it therefore immediately emerges back from the right
border. Importantly, each particle i interacts with the closest periodic image of the
other N − 1 particles even if they were in the adjacent cell. As a result, one is able
to simulate the bulk properties of the system with just a small number of particles.
However, great care must be taken to choose the cut-off distance properly, so that
particles do not interact with their own periodic images. The rcut is consequently
at most L/2, where L is the size of the cubic simulation box [31].
One problem arising from the cut-offs used for van der Waals interactions is the
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mapping of the long-range electrostatic interactions. Unlike the Van der Waals
potential, electrostatic interactions decay slowly and thus cannot be neglected at
distances larger than rcut. Fortunately, there is a number of ways able to tackle this
problem. Today, the most accurate and computationally efficient technique is the
so-called Particle Mesh Ewald (PME) method [171, 172].
When including the periodic images, the electrostatic potential of N interacting
particles is given by the following Ewald sum:
HEwald,Coulomb = 1
2
N∑
i
N∑
j
′∑
|n|
qiqj
|rij + n| , (4.7)
where rij is the interparticle distance vector from atom i to j and n is the box index
vector n = (nxL, nyL, nzL), where the nx, ny, and nZ are integers. Accordingly,
the denominator represents the real distance between charges i and j. The prime
symbol in the sum indicates that n = 0 when i = j, so that the denominator is
well defined. Ewald’s trick [173] was to render this slowly converging sum into two
rapidly-converging terms combined with a correction term
HEwald,Coulomb = HEwald,real +HEwald,recip +HEwald,corr, (4.8)
where the first term is evaluated in real space while the second is solved in reciprocal
space. Following certain algebraic manipulations, the real space sum is given by
HEwald,real = 1
2
N∑
i,j
qiqj
′∑
|n|
erfc(β|rij + n|)
|rij + n| , (4.9)
where the complementary error function erfc is defined as
erfc(x) = 1− 2√
pi
∫ x
0
exp(−t2)dt. (4.10)
Meanwhile, the reciprocal sum can be expressed as
HEwald,recip = 1
2piL3
N∑
i,j
qiqj
∑
|m|6=0
exp(−pi2|m|/β2)
|m|2 exp[2piim · (ri − rj)], (4.11)
and the final correction term then reads
HEwald,corr = −β√
pi
N∑
j=1
q2j , (4.12)
where m is a reciprocal box vector and β determines the relative weight of the
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real and reciprocal sums. In real space, the sum is calculated directly according
to the cut-off while the reciprocal sum is spread onto a discrete grid with multidi-
mensional piecewise interpolation. Fortunately, reciprocal energy and force terms
are expressed as convolutions and can therefore be evaluated quickly using the Fast
Fourier Transform (FFT) algorithm. As a result of applying FFT, the PME method
provides a significant improvement to the simulation algorithm’s runtime behavior
when calculating electrostatic interactions [31].
Similarly, controlling the proper statistical ensemble requires the exploitation of
certain computational shortcuts. By default, the MD algorithm produces a micro-
canonical NVE (constant number, constant volume, and constant energy) ensemble.
Yet, biological systems often allow volume and energy to fluctuate while the tem-
perature and pressure are instead kept constant. Reaching these isothermal-isobaric
(NpT) conditions through simulations therefore requires the utilization of thermo-
and barostats forcing the temperature and pressure to stay constant (within ther-
modynamic fluctuations) during the run.
Like with many schemes discussed above, also thermo- and barostats have multi-
ple implementations to choose from. For instance, in this Thesis we applied the ones
called the velocity rescaling (v-rescale) thermostat [174] and the Parrinello–Rahman
barostat [175]. The former controls the temperature by rescaling the velocities of
the constituent particles with a properly chosen stochastic factor. This ensures a
correct kinetic energy distribution
dEkin = (Ekin,0 − Ekin)dt
τt
+
√
EkinEkin,0
Nf
dWw√
τt
, (4.13)
where Ekin,0 is kinetic energy of the coupled thermal reservoir, Ekin is the current
kinetic energy, τt is the time constant, Nf is the number of degrees of freedom, and
dWw is a Wiener process. The advantage of the v-rescale thermostat is the first order
decay of temperature deviations and the lack of oscillations, while still producing
a correct statistical ensemble. Similarly, the Parrinello–Rahman barostat gives the
true NpT ensemble. It controls the pressure P by allowing the volume V of the box
to fluctuate according to the matrix equation of motion
db2
dt2
= VW−1b′−1(P−Pref), (4.14)
where b is the matrix representing the box vectors, Pref is the reference pressure
while W is the matrix parameter that determines the strength of the coupling and
how strongly the box can be deformed. Its inverse is defined as
W−1 =
4pi2αij
3τ 2pLmax
, (4.15)
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where αij is the isothermal compressibility, τp is the time period of pressure fluctu-
ations, and Lmax is the largest box matrix element. If applied when system is not
properly equilibrated, the Parrinello–Rahman coupling may result in overly high
box fluctuations, yet it is a reliable choice for an MD barostat.
In MD, certain constraints are usually applied to augment the equations of mo-
tion by freezing the highest-frequency interactions. With fastest vibrations removed
from the model, the simulation timestep can be increased considerably, thus allow-
ing one to explore longer timescales. Furthermore, fixing the bond lengths does not
significantly alter the dynamical properties of the system. Fixing the intraparticle
bond angles, on the other hand, often leads to biased dynamics. Nowadays, the
most common algorithm to constrain non-solvent molecules is called LINCS (Lin-
ear Constraint Solver) [176], whereas another, faster but less flexible one, named
SETTLE [177], is applied to constrain solvent molecules like water.
4.2 Umbrella Sampling Method for Measuring Free Energies
The calculation of free energy differences with MD simulations is a key application
in computational biophysics [178–180]. This is because free energy differences are
the driving forces for every physical or chemical process, such as the adsorption of a
ligand to its receptor. Consequently, partitioning and mean position of such a ligand
can be described with a free energy profile which, in theory, could be obtained from
unbiased MD simulations [180]. In practice, however, the non-ergodicity of those
systems severely hinders the sampling of the process at reachable timescales. This
means that states with low probability (i.e. high energy) are not sampled sufficiently,
as the probabilities for such processes are obtained according to the Boltzmann factor
exp(−A/kBT ), (4.16)
where A is the Helmholtz free energy. For example, if the barrier A is much higher
than 10 kBT , the statistical probability for a spontaneous process at a physiological
temperature becomes extremely low.
Umbrella sampling [181] is a method where system’s ergodicity is expanded artifi-
cially by the use of harmonic restraining potentials [178]. These potentials act along
a certain reaction coordinate ξ to drive the system from a thermodynamic state A
to B. The reaction path is then divided into Nw intermediate steps, as shown in
Figure 4.4 which illustrates the basic concept of umbrella sampling. In practice,
each of these steps is an individual sampling window where an MD simulation is
conducted in order to obtain the biased distribution of the system along the reac-
tion coordinate ξi (i = (1, . . . , Nw)). These windows are forced to overlap, so that
the individual distributions can later be unbiased and combined to a single global
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P(ξ)
ξ
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Figure 4.4: The principle of umbrella sampling. As the system passes from a thermo-
dynamic state A to state B along a reaction coordinate ξ, such as in this figure where
the ligand molecule (HA) is pulled away from its binding site on the surface of a pro-
tein (CD44 HABD), its displacement trajectory is sliced into separate sampling windows.
When simulated individually with restraints, these sampling windows produce a biased
sampling distribution each representing a small part of the process. The free energy is
then calculated based on these overlapping distributions.
distribution based on which the final free energy profile is then calculated from.
Theoretically, obtaining the free energy profiles from MD simulations is not a
straightforward task. In describing the state of a system with N particles, a total of
6N dimensions are required to describe the so-called phase space of the system [182].
That is, every particle is described with three spatial and three momentum coordi-
nates. However, free energy is not simply a function of these phase space coordinates
of the system, but rather related to the canonical partition function Q [178].
The Q can be calculated by integrating over the whole phase space [178]. If the
potential energy E is independent of momentum, Q is obtained simply as
Q =
∫
exp[− 1
kBT
E(r)]dNfr. (4.17)
In a canonical ensemble, the number of particles, volume, and temperature are kept
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fixed, and as a result the Helmholtz free energy is related to Q via
A = −kBT lnQ. (4.18)
If pressure, on the other hand, is kept constant instead of temperature, the Gibbs
free energy is obtained. This is relevant especially in biological systems, as water is
non-compressible. Therefore, in MD simulations of biological systems, ∆A and ∆G
are numerically almost indistinguishable.
In many cases the thermodynamic states A and B are separated by a simple
reaction coordinate ξ. In principle, it can be defined in several ways, such as a
change in the Hamiltonian. Most often it is, however, a geometric parameter like
distance or torsion between two atoms or groups of atoms [178]. In this Thesis, it
was chosen to be the distance between the centers-of-mass of CD44 and the HA
oligomer along one coordinate in the Cartesian space.
When ξ is defined, all the other degrees of freedom can be integrated out of Eq.
(4.17) to obtain a probability distribution of the system along ξ:
Q(ξ) =
∫
δ[ξ(r)− ξ]exp[− 1
kBT
E]dNfr∫
exp[− 1
kBT
E]dNfr
, (4.19)
where Q(ξ)dξ is the probability of the system to reside in a short interval dξ around
ξ. However, the problem is that in computer simulations direct phase space integrals
like Eq. (4.19) are impossible to calculate. Fortunately, if the system is assumed to
be ergodic, like in umbrella sampling, the ensemble average Q(ξ) is equal to the time
average P (ξ). As a result, A(ξ) also known as the potential of mean force (PMF) is
according to Eq. (4.18) defined as
A(ξ) = −kBT lnP (ξ), (4.20)
and it is thereby directly obtainable from computer simulations [178].
To ensure the sampling of all regions along the reaction coordinate ξ, a biasing
potential wi is applied in every simulation window i to hold the system in a given
position [178]. Importantly, wi is an additional energy term and depends only on ξ:
Eb(r) = Eu(r) + wi(ξ), (4.21)
where ’u’ and ’b’ refer to unbiased and biased quantities, respectively. The most
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common wi(ξ) is a harmonic biasing potential of the following form:
wi(ξ) =
Ki
2(ξ − ξrefi )2
, (4.22)
which restraints the system at a position ξrefi (i = 1, . . . , Nw) with a force constantKi
(i = 1, . . . , Nw), thereby producing the biased distribution of the system along the
reaction coordinate ξ in each window Nw. The choice of K is of crucial importance
in umbrella sampling, as too lowK will cause the system to avoid the low probability
regions whereas too highK will not produce sufficient overlap between the individual
distributions.
The unbiased free energy Ai(ξ) is obtained from the unbiased probability distri-
bution in each window. According to Eq. (4.19), the latter is written as
P ui (ξ) =
∫
δ[ξ′(r)− ξ]exp[− 1
kBT
E]dNfr∫
exp[− 1
kBT
E]dNfr
. (4.23)
Biased distribution is, on the other hand, in accordance with Eq. (4.21) written as
P bi (ξ) =
∫
δ[ξ′(r)− ξ]exp[− 1
kBT
(E(r) + wi(ξ
′(r)))]dNfr∫
exp[− 1
kBT
(E(r) + wi(ξ′(r)))]dNfr
. (4.24)
Because the bias caused by wi(ξ) depends only on ξ and the integration is performed
over all degrees of freedom except ξ, Eq. (4.23) and Eq. (4.24) can be combined
into one relation:
P ui (ξ) = P
b
i (ξ)exp[
1
kBT
wi(ξ)]〈exp[− 1
kBT
wi(ξ)]〉. (4.25)
Now, by realizing that P bi (ξ) is obtained from MD simulations and that wi(ξ) is
given analytically, the unbiased free energy for the ith window is
Ai(ξ) = −kBT lnP bi (ξ)− wi(ξ) + Fi, (4.26)
where the undetermined constant Fi represents the free energy related to applying
the window potential [178]. It is defined from the result known as the Jarzynski
equality [183]:
exp[− 1
kBT
Fi] = 〈exp[− 1
kBT
wi(ξ)]〉, (4.27)
which, given enough sampling, is sufficient to unbias the simulation as long as it
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spans the whole ξ [178].
In addition to just unbiasing, the individual distributions must also be combined
in order to be able to compute the global PMF. This means that the constant Fi
needs to be calculated and, as it is not directly obtainable from sampling, special
methods are required. From these, the most established one is called the Weighted
Histogram Analysis Method (WHAM) [184]. It offers a way to estimate Fi and,
at the same time, to minimize the statistical error of P u(ξ) through an iterative
process. The central idea is that the global distribution is based on the weighted
average of the individual window distributions:
P u(ξ) =
Nw∑
i
pi(ξ)P
u
i (ξ), (4.28)
where pi denotes weights assigned to the individual distributions. They are chosen
to minimize the statistical error of P u in such a way that
∂σ2(P u)
∂pi
= 0, (4.29)
where normalization is done such that
∑
pi = 1. As a result,
pi =
ai∑
j aj
, ai(ξ) = Niexp[− 1
kBT
wi(ξ) +
1
kBT
Fi], (4.30)
where Ni denotes the total number of simulation steps in the window i. The constant
Fi is, in turn, calculated by integrating the right hand side term from Eq. (4.27)
over ξ to obtain
exp[− 1
kBT
Fi] =
∫
P u(ξ)exp[− 1
kBT
wi(ξ)]dξ
=
∫
exp[− 1
kBT
(A(ξ) + wi(ξ))]dξ.
(4.31)
Now, by iterating Eq. (4.28) and Eq. (4.31) for P u and Fi until convergence,
Eq. (4.26) can be applied to construct the global PMF profile. The speed of the
convergence, however, depends on the number of umbrella windows and on the
height of the existing free energy barriers [178].
On a more practical side, Hub et al. [185] introduced a WHAM implementation
called g_wham that works with the GROMACS simulation software package. In
addition to evaluating the PMF profiles of the system in an above-mentioned way,
it offers estimates of statistical errors by employing a technique called the bootstrap
analysis [186].
The principle of the bootstrap analysis is to generate hypothetical observations
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using the existing umbrella histograms hi(ξ) as a template [185]. In other words,
bootstrapped trajectories ξb,i(t) for each umbrella histogram hi(ξ) are obtained based
on existing probability distributions of ξi (i = 1, . . . , Nw). These virtual trajectories
then form a new set of Nw histograms hb,i that are subsequently given as input
to WHAM yielding a bootstrapped PMF Wb(ξ). After repeating this procedure
Nb times, a total of Nb bootstrapped PMFs Wb,k(ξ) (k = 1, . . . , Nb) is acquired.
Notably, in this study, Nb was set to a value of 200.
As a result of having multiple trajectories, the error in the PMF is evaluated
simply by taking the standard deviation of the bootstrapped PMFs with
σPMF (ξ) = [(Nb − 1)−1
Nb∑
k=1
(Wb,k(ξ)− 〈Wb(ξ)〉)2]1/2, (4.32)
where 〈Wb(ξ)〉 = N−1b
∑Nb
i=k(Wb,k(ξ) is the average of the bootstrapped PMFs at
the position ξ. If the sampling in each window Nw is limited due to relatively long
autocorrelation times, such as in conformational sampling of macromolecules, it is
recommended to perform multiple simulations of each window with a random seed.
However, when sampling is sufficient, the bootstrapping procedure is accurate and
gives reasonable error estimates [185].
4.3 Model Systems and Simulation Parameters
In this study, the simulated systems consisted of differentially glycosylated CD44
proteins and HA oligosaccharides with various sizes. The system was initially con-
structed by downloading the crystal structure of a human CD44 HABD by Teriete
et al. [15] from the Protein Data Base with the identifier 1UUH. After this, the fol-
lowing steps were taken. First, a second monomer and all the water molecules were
removed from the model in order to have a system of one CD44 protein. Second, the
1UUH structure contained two selenomethionines, artificial amino acids that help
the structure elucidation of proteins in x-ray crystallography, at positions 63 and 66
that needed to be replaced with normal methionine residues. The proper topology
was then created with the GROMACS tool pdb2gmx, after which the protein was
placed at the center of a simulation box of 8 nm× 8 nm× 8 nm in size.
The topologies of the HA oligomers were generated based on GLYCAM06 [167]
force field parameters. We abbreviate the HA oligomers used in this study as HA4,
HA6, HA8, and HA16, with the suffix denoting the number of monosaccharides in
a given fragment. In order to build these HA oligomers, a special program was
created. It reads a residue database of monosaccharides and subsequently concate-
nates the carbohydrate monomers in a certain conformation. The program also
adds the correct end groups (hydroxyl groups and hydrogen atoms) to the termi-
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Asn25
Asn100
Asn110
Asn55
Asn120
Figure 4.5: Amino acid residues selected for glycosylation. The selection was made
based on the proximity to the binding site. All in all, Asn25, Asn100, and Asn110 were
glycosylated, each in separate systems, while Asn57 and Asn120 were left unmodified. The
dashed arrow denotes the HA binding surface.
nal monosaccharides. Before incorporation into the final model, the ready-made
HA fragments were still geometry optimized with a program called Avogadro [187],
employing steepest the descent algorithm and the MMFF94 force field.
CD44 was glycosylated by covalently adding core pentasaccharides to its surface.
Three of the five potential N -glycosylation sites (Asn25, Asn100, Asn110) were
chosen to be glycosylated, so that only one carbohydrate was added per simulation
system. The selection of the N -linkage sites was made based on the proximity to
the HA binding groove, as illustrated in Figure 4.5. Residues Asn57 and Asn120
were left unglycosylated because they reside on the opposite side of the protein
and are therefore less likely to directly affect the binding of HA oligomers. The
pentasaccharides were also built with a custom-made program. It attaches the sugar
4. Computational Methods and Simulation Parameters 47
residues to a given Asn residue of the protein and provides the user with a correct
topology file. Notably, one has to be aware that AMBER and GLYCAM06 force
fields do not share the same scaling factors. Because proteins are very sensitive to
changes in the scaling factors, the modifications had to be subjected to the sugar
parameters. The automatic topology builder program for glycosylated proteins was
therefore programmed to convert the pentasaccharide topology parameters to match
AMBER scaling factors. Importantly, this and all the aforementioned programs are
available at Ref. [188].
Given the large variance in the size, glycosylation scheme, and conformational
status of the studied HA and CD44 structures, multiple systems were simulated.
Table 4.1 lists all of these simulations and designates which modifications were made
or observed in their structures. In all of the systems the protein was initially placed
at the center of the simulation box, after which water and salt (NaCl) were added
to give the physiological concentration (150 mmol/l) of salt in each system, thereby
reflecting the conditions inside the extracellular fluid, such as blood plasma. In
addition to this, extra Na+ ions were added to render the system electrically neutral,
as both CD44 and HA bear a negative total charge. Lastly, before conducting any
actual production simulations the systems were carefully energy minimized.
All the simulations were performed with the GROMACS version 4.6.3 [161]. The
initial energy minimization was always conducted with the following sequence of
steps. First, each system went through 1000 steps of steepest descent minimization
with a 1 fs timestep. To ensure that the system was properly balanced, this was
followed by 1000 steps of conjugate gradient minimization with a 2 fs timestep. In
production simulations the integration was performed by the leap-frog algorithm
with a 2 fs integration timestep. Furthermore, in contrast to the minimization runs
where there were no bond constraints applied to non-water molecules, the production
simulations utilized the LINCS algorithm to keep the bond distances fixed. The
TIP3P water model and the SETTLE algorithm were employed for modeling and
constraining the water molecules, respectively.
The simulations were performed under periodic boundary conditions in all direc-
tions along with PME electrostatics to take care of the long-range electrostatics. A
cutoff distance of 1 nm was used with the short-ranged Lennard-Jones interactions
and neighbor lists. Furthermore, all simulations were conducted in the NpT ensem-
ble, so that the v-rescale thermostat was employed to couple the systems to a heat
bath that was set to a physiological human body temperature, 310 K, with a time
constant of 0,1 ps. Separate heat baths were used for the biomolecules under study
and the salt water surrounding them. Lastly, the Parrinello–Rahman barostat cou-
pled the systems isotropically to a reference pressure of 1 bar, with a time constant
of 1 ps and a compressibility of 4.5× 10−1 bar−1.
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Table 4.1: Simulations in this Thesis. The first column gives an abbreviation for each sim-
ulation. The second column describes the systems’ contents. Importantly, if a spontaneous
flip to the B-form conformation was observed, it is designated in brackets. Furthermore,
free energy calculations are denoted as "Umbrella", and if the protein was glycosylated
it is marked with the name of the attachment residue. Lastly, the third column gives
the duration of the simulation trajectory, and the fourth column reports the size of the
simulation box.
Name Description Duration (ns) Size (nm)
S1 CD44 with HA16 1 1000 9× 9× 9
S2 CD44 with HA16 2 (B-form) 1700 10× 10× 10
S3 CD44 with HA16 3 1000 10× 10× 10
S4 CD44 with HA16 4 1000 10× 10× 10
S5 CD44 with HA8 1000 9× 9× 9
S6 CD44 glycosylated at Asn25 500 8× 8× 8
S7 CD44 glycosylated at Asn100 (B-form) 1000 8× 8× 8
S8 CD44 glycosylated at Asn110 500 8× 8× 8
S9 CD44 glycosylated at Asn25 +HA16 1000 11× 11× 11
S10 CD44 glycosylated at Asn100 +HA16 1000 11× 11× 11
S11 CD44 glycosylated at Asn110 +HA16 1000 11× 11× 11
S12 Umbrella: CD44 +HA4 19 × 100 9× 9× 9
S13 Umbrella: CD44 +HA8 1 34 × 100 10× 10× 10
S14 Umbrella: CD44 Asn25 +HA8 outwards 36 × 100 10× 10× 10
S15 Umbrella: CD44 Asn25 +HA8 inwards 25 × 100 10× 10× 10
S16 Umbrella: CD44 +HA8 2 32 × 100 10× 10× 10
S17 PD-CD44 500 10× 10× 10
S18 PD-CD44 +HA8 2 500 10× 10× 10
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5. SIMULATION RESULTS REVEAL HOW
CD44 IS REGULATED
This chapter presents the results of this study, compares them to existing literature,
and discusses their biological significance. For extracting relevant information from
the simulation trajectories we used both ready-made GROMACS analysis tools [161]
and our own data-extraction programs. The latter were mainly scripted with the
Python 2.7 programming language [189], but also with the MATLABr numerical
computing environment. All the snapshot pictures were visualized with VMD [35]
and rendered with the Tachyon ray tracing library [190].
The main objective of this Thesis is to explore the effects of HA size, CD44
glycosylation, and CD44 conformation transitions on the protein-carbohydrate in-
teraction. Accordingly, this chapter is divided into three sections each describing
one of these topics. The first section compares the residual binding profiles for HA8
and HA16 and presents the binding free energy profiles for HA4 and HA8.
The second section reports the results for the glycosylated proteins. First, the vi-
ability of our models is verified by comparing the N -linkage dihedral angles to known
literature. Again, residual binding profiles show how each glycosylation changes the
adsorption pattern of HA16. Free energy profiles then present compelling thermody-
namic evidence of how a glycosylation inside the binding groove affects the binding
process.
The third section discusses the two previously characterized conformation changes
of the CD44 HABD. First we assess the enhancement of binding related to the un-
folding of the C-terminal tail and compare our findings to a previous computational
study [18]. We also report our somewhat provocative findings regarding the sharp
and local A-to-B transition. Importantly, the structure of our protein model is ini-
tially in the O-state (C-terminus is confined) and in the A-form (Arg41 side-chain is
open). Therefore, all the following simulation results are obtained, unless reported
otherwise, for this conformation.
5.1 Ligand Size Affects the Strength of Binding
To measure the contribution of each CD44 amino acid to the binding of the HA
oligomer, we calculated the average hydrogen bonds and minimum distances between
HA16 and every residue of the protein from simulations S1, S2, S3, and S4. For this
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purpose, we used two geometric criteria to define the hydrogen bonds. The distance
cut-off between the hydrogen and the donor atom was set to 0.35 nm, and the
angle cut-off in the triplet formed by the hydrogen, acceptor, and donor atoms was
limited to 30 ◦. In Figure 5.1, the calculated profiles are compared with similar
graphs derived from simulation S5, where HA16 was replaced by a two times shorter
HA8.
Collectively, the data shows three regions important for the binding. First, the
core of the binding groove is formed by Arg41, Lys78, and Arg79, with Arg41 making
two constitutive hydrogen bonds with the bound HA. Second, residues 108 to 113,
located in the loop between the β5 and β6 strands, appear to have a relatively high
contribution in the binding, forming on average five hydrogen bonds with the bound
HA oligomer. Third, the Arg154 and the other residues from the C-terminal end
seem to have an effect only when the ligand is long enough. The last observation
is particularly interesting because at least two of the previous studies claim [16, 18]
that the contribution from Arg154 is negligible, while demonstrating this only with
HA8. By comparison, our results indicate that at least HA16 is capable of forming an
average of one hydrogen bond with Arg154 and thus implying that the interaction
is energetically meaningful.
After clearly defining the principal binding site, we carried out two umbrella sam-
pling simulation sets to measure the effect of HA chain length on the strength of the
interaction at this particular region. It was done as follows. First, the starting struc-
tures for the steered MD simulations were taken from snapshots of spontaneously
bound CD44-HA complexes. After this, a harmonic biasing potential was applied
to pull the center of mass (COM) of a stably bound HA away from the binding
groove. Being more specific, 40 ns simulations were used to pull the HAs (HA4 and
HA8) along the reaction coordinate with a force constant of 1000 kJ mol−1 nm−2 and
a pulling rate of 0.1 nm ns−1. Furthermore, the reference pull group was selected to
be the backbone of residues 75–79. These amino acids are buried inside the "back
wall" of the binding groove and their fluctuations are therefore minimal compared
to other residues at the same site. As a result, they impose very little statistical
error to the subsequent free energy calculations.
To ensure that the pulling of HA was executed only in one direction, and to sig-
nificantly reduce the complexity of the process, the protein was restrained in space,
so that the binding groove was directly facing the x-axis (the reaction coordinate ξ),
as illustrated in Figure 5.2. The restraining was, in essence, conducted by choosing
three benchmark points from the protein backbone (Cα atoms from residues Thr47,
Phe56, and Gln65) to be subjected to a restraining potential. This choice was, in
turn, made based on two criteria. First, the atoms had to be located as far from the
binding groove as possible to avoid skewing the interactions with the bound HA.
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Figure 5.1: Hydrogen bond and minimum distance profiles per residue for two cases, with
HA8 and HA16, as marked in the legends of the figures. The values for HA16 are averaged
from simulations S1, S3, and S4, where HA was stably bound and the Arg41 side-chain was
in the A-conformation through the simulations. The profiles for HA8 are calculated from
the simulation S5. The first 50 ns were discarded from the analysis in each case.
5. Simulation Results Reveal How CD44 is Regulated 52
COMCD44 COMHA
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
Distance from the binding site ξ (nm)
Figure 5.2: A snapshot figure representing the simulation setup. The protein is restrained
into this position by freezing the positions of three backbone atoms (atom numbers 347,
559, and 692). Furthermore, the reaction coordinate is the distance from the back of the
binding site (the backbone atoms of residues 75 to 79). The Arg41 residue in the border
of the binding site is shown in order to clarify the orientation of the protein.
Second, the atoms had to have relatively low root-mean-square fluctuations, so that
restraining them would impose only a minimal bias to the overall structure of the
protein.
Starting structures for umbrella sampling windows were then collected as snap-
shots from the pulling simulation and spaced 0.10± 0.01 nm apart along the x-axis.
These were chosen to achieve equal sampling along the whole reaction coordinate ξ.
In each window, the HA oligomer was constrained only in x-direction and was thus
allowed to move freely in the corresponding yz-plane. The pull groups and the force
constants were exactly the same as in the previous pulling simulations. From the
100 ns sampling windows, only 80 ns was used for the actual free energy calculation,
as the first 20 ns were regarded as equilibration, and therefore cropped from the
real analysis. The final free energy profiles and their statistical error estimates are
presented in Figure 5.3.
The results confirm our previous observations. In both cases the free energy
minimum lies at a distance of 0.9 to 1.3 nm from the reference pull group, which
corresponds to the position of the Arg41 (Figure 5.2). From the two ligands, the
HA tetramer has a binding free energy ∆Gb of roughly -7.5 kJ mol−1 (≈ 3 kBT in a
temperature of 310 K). This binding energy is in the order of thermal fluctuations
and the ligand is therefore able to make only transient interactions with CD44. Now,
it is worthwhile to realize that to be able to collectively facilitate, for instance, the
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Figure 5.3: Free energies for the binding of HA tetramer and octamer. The free energies
from simulation S12 are given in , and from simulation S13 in with their error
limits shaded accordingly. The horizontal axis is equivalent to the one in Figure 5.2 and
the horizontal dashed lines at 1 nm and 4 nm mark the positions of the Arg41 side-chain
and the threshold for bulk water, respectively.
rolling of the leukocytes, the individual CD44-HA interaction needs to be reversible
(i.e. close to the energy scale of thermal fluctuations). Our results, however, show
that the binding between the HA octamer and CD44 is, at least in the absence of any
external forces such as the drag caused by the blood flow, rather irreversible with
∆Gb of -25 kJ mol−1. This finding therefore suggests that some dynamic mechanism
is required to control the binding affinity of longer HA polymers.
The binding free energy has also recently been estimated with wet-lab exper-
iments. Banerji et al. [191] measured the dissociation constant kD of individual
CD44-HA interaction, using a surface plasmon resonance and non-linear curve fit-
ting to Langmuir isotherm, to be 65.7 µm. Fortunately, the dissociation constant is
related to ∆G via
∆G = RT ln
(kD
c	
)
, (5.1)
in which R is the ideal gas constant and c	 = 1.0 mol L−1 is the standard reference
concentration. By plugging in the values we can estimate that
∆G = 8.314 J mol−1 K−1 × 310 K ln
(65.7× 10−6 mol L−1
1 mol L−1
)
= −24820.84512 J mol−1
≈ −24.8 kJ mol−1,
which is remarkably close to the approximate height of the free energy barrier for the
adsorption of HA8 that we calculated with umbrella sampling. It should, however, be
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Table 5.1: Angles in the carbohydrate-protein attachment. Asn25, Asn100, and Asn110
designate the amino acid residue of the N -linkage.
Angle or dihedral Asn25 Asn100 Asn110 Reference value [33]
O5-C1-Nδ1 103.68 104.862 105.356 106.8
C2-C1-Nδ1 113.319 112.955 113.101 111.1
C1-Nδ1-Cγ 123.618 123.813 122.802 121.4
O5-C1-Nδ1-Cγ -113.528 -90.2792 -90.7735 -100.0
C1-Nδ1-Cγ-Cβ 115.988 26.3762 -74.3934 -179.0
Nδ1-Cγ-Cβ-Cα -139.379 19.6102 -103.687 -172.0
Cγ-Cβ-Cα-N 96.9236 -80.5216 -72.1692 -69.0
noted that their result is measured for a high molecular weight HA and is therefore
not strictly comparable to our findings.
5.2 Glycosylations Modulate Native Binding Interactions
We modeled glycosylations to study how the covalently attached carbohydrates on
the surface of the protein regulate the binding affinity of the HA oligomers. At
first, we carried out three 500 ns simulations (S6, S7, and S8), with the glycosylated
proteins, but without any ligand, to see how the pentasaccharides would orient
themselves relative to the body of the protein and what effect does their presence
have on its stability. Fortunately, previous analyzes of N -linkages on glycoproteins
have provided information about the stereochemistry at the carbohydrate-protein
attachment. So, the average angles and dihedrals from the N -linkages are tabulated
and compared to this reference data in Table 5.1. As the data shows, the bond
angles are remarkably well in line with the literature values. In comparison, the four
dihedrals which determine the orientation of the attaching GlcNAc with respect to
the local protein backbone exhibit more variance when compared to the reference
values. Analysis of the previous x-ray data has, however, revealed that it is common
for these dihedral angles to have broader distributions that vary according to the
surroundings of the attachment site [33]. Furthermore, our measurements of root-
mean-square deviations (RMSD) indicate that the structural stability of CD44 is
not affected by the pentasaccharides (data not shown).
The final frames from simulations S6, S7, and S8 are presented as snapshots in
Figure 5.4. These pictures show that, in their final configurations, Asn100 and
Asn110-linked pentasaccharides protrude into the water phase, whereas the Asn25-
linked one prefers to clutch to the side of the protein forming a lid over the binding
groove. It thereby gives a plausible explanation for why the glycosylation of Asn25
has been observed to modulate the binding of HA in a particularly discrete man-
ner [10].
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A) B)
C) D)
Figure 5.4: CD44 HABD with the three glycosylation schemes. A), B), and C) show the
ending frames from the simulations S6, S7, and S8 as snapshot pictures, where the protein
is illustrated with a surface and the attached carbohydrates with a licorice presentation.
Panel D shows the three structures aligned on top of each other. The surrounding salt
water and hydrogen atoms of the carbohydrates are omitted for clarity.
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To further test this hypothesis, we measured the thermodynamic effect of the
presence of a pentasaccharide in Asn25 to the binding of HA octamer. For this
purpose, the method of choice was again the umbrella sampling technique. Similarly,
the orientation of the protein and the selection of the simulation parameters were
mostly the same as shown in Figure 5.2 and as described in the previous section,
respectively. The main exception was, however, that now the bound HA was placed
in between the protein and the pentasaccharide (simulation S14). We recognize that
this configuration is probably not a naturally-occurring one, but nevertheless it can
act as a thermodynamic reference configuration. Now it was also possible to use
exactly identical atomic coordinates for both systems, with and without the added
pentasaccharide (simulation S16) and thus gain more comparable data. Overall, the
free energy calculation proceeded with the following sequence of steps. First, the
HA8 was pulled outwards from the binding groove so that it was forced to bend
the attached carbohydrate on its way. After this, we took a frame from the middle
of the pulling simulation where HA had already released itself and was now facing
the pentasaccharide from the side of the water phase. The frame then served as a
starting structure for an opposite pulling simulation, this time forcing HA back to
the binding groove that was now occupied solely by the pentasaccharide (simulation
S15).
For measuring the free energy, the pulling simulations were divided into a series
of umbrella sampling windows. To achieve sufficient sampling of the whole reaction
coordinate, even when pushing towards the pentasaccharide, the harmonic force
constantK was set to 2000 kJ mol−1 nm−2 in sampling windows 1–6 of the simulation
S14 and in every window of the simulation S15. Similarly, in order to have more
accurate estimates of the position of the ligand, the pull group was changed to be
just the ring atoms of the fourth carbohydrate unit in the HA octamer.
The free energy profiles along with their statistical error estimates are presented
in Figure 5.5. In simulation S14 (red graph) the free energy difference from the
binding groove to the bulk water is roughly -55 kJ mol−1 with a sharp minimum at
0.8 nm from the reference point, designating that when HA is artificially trapped to
this position the native binding interactions are enhanced. Most importantly, the
core pentasaccharide at Asn25 causes steric hindrance preventing the trapped HA
from detaching. Similarly, in simulation S16, in the system without the obstructing
pentasaccharide, the HA octamer finds a strong free energy minimum from the
binding groove (blue graph in Figure 5.5). This time the binding free energy is
about -33 kJ mol−1, which is slightly higher than in a corresponding simulation S13.
The reason for this discrepancy lies most likely in the different starting frames, where
the position of the bound ligand was not identical, in turn implying that distinct
ligand binding modes may exist even within the same binding site.
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Figure 5.5: Free energies for the binding of the HA octamer to the glycosylated CD44.
The free energies from the simulation S14 are given in , simulation S15 in , and
simulation S16 in with their error limits shaded accordingly. The horizontal axis is
again equivalent to the one in Figure 5.2 and the horizontal dashed lines at 1 nm and 4 nm
mark the positions of the Arg41 side-chain and the threshold for bulk water, respectively.
While in the simulation S14 the binding grove is clearly the global minimum
along the reaction coordinate, the simulation S15 shows that in a more realistic
situation where the HA octamer is attempting to dock into the glycosylated binding
groove, the attached pentasaccharide effectively blocks most of the native binding
interactions. In other words, the inward-out and outward-in processes for ligand
binding are fundamentally different when the protein is glycosylated at Asn25. In
a normal adhesion event, once HA approaches the binding groove, the positively-
charged Arg41 starts to attract it intensively, as illustrated by a very steep free
energy gradient in the distance interval of 0.8–1.1 nm. However, the absence of
this gradient in the free energy curve corresponding simulation S15 (green graph in
Figure 5.5) means that the steric repulsion of the core pentasaccharide prevents the
ligand from aligning correctly into the binding groove. As a result, a shallow free
energy minimum lies now at 1.5 nm, outside the reach of the Arg41 side-chain. All
in all, the strength of the binding, roughly -19.5 kJ mol−1, is reduced by 40 % from
the unglycosylated case.
The above conclusion is further backed by the hydrogen bond and minimum dis-
tance profiles shown in Figure 5.6. They are calculated from the simulations S9, S10,
and S11, so that the last residues, ranging from 170 to 174, represent the five carbo-
hydrate monomers of the attached pentasaccharide. Upon analyzing these graphs, it
is apparent that glycosylating Asn25 will moderately decrease the overall number of
hydrogen bonds between the ligand and the protein, at least when compared to the
non-glycosylated hydrogen bond profiles in the previous section, whereas the other
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Figure 5.6: Hydrogen bond and minimum distance profiles for the glycosylated CD44
proteins from the simulations S9, S10, and S11, and the legends give the name of the linking
residue. The first 50 ns were not included in the analysis to make sure that the profiles
represent real binding interactions. Furthermore, the residues 170 to 174 in the profiles
now represent the carbohydrate units of the attached pentasaccharide.
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glycosylations seem to have no effect at all. In all cases the overall shape of the
hydrogen bond and minimum distance profiles correlates with the non-glycosylated
ones, displaying only few exceptions. Firstly, of the three simulation trajectories an-
alyzed, only in the simulation S10 the bound HA16 is interacting with the attached
pentasaccharide with more than one hydrogen bond. Interestingly, these interactions
are enough to draw the HA strand into the upper part of the binding groove so that
it forms on average 3.5 hydrogen bonds with the residues Arg90, Pro93, and Asn94
from which Arg90 has the strongest contribution of 1.88 hydrogen bonds. Secondly,
it seems that the HA16 ligand is continuously connected to the main binding cluster
formed by Arg41 and Arg78 with two hydrogen bonds, but to which one depends
on its orientation inside the binding groove. We return to this matter later.
Our results fortify the idea of covalently attached carbohydrates, especially when
linked to Asn25, regulating the binding affinity between HA and CD44. Further-
more, in light of our simulation data, all the glycosylation sites are not equally
important, as Asn25 blocks the adhesion, Asn100 enhances it, and Asn110 seems to
have no apparent effect.
5.3 Conformation Change in the Binding Site Detaches the
Ligand
In order to find out which regions of CD44 HABD have the most prominent struc-
tural displacements, we analyzed the root-mean-square fluctuations (RMSFs) of the
protein backbone from the simulations S1, S2, S3, and S4. The procedure started by
aligning the atomic coordinates of each simulation frame with a reference frame (the
end structure of the protein in a given simulation) and continued by computing the
mean squared deviation between these coordinates and the ones from the reference
frame via equation:
RMSFi =
√√√√1
t
t∑
tj=1
(ri(tj)− rrefi )2, (5.2)
where ri(tj) is the position of a given atom i, rrefi is the atomic positions in the
reference frame and t is the time [161]. We then calculated the residual RMSF
profile by averaging the values of individual backbone atoms for each amino acid
residue. As seen from Figure 5.7 the results are remarkably homogeneous. The Link
module (residues 23–132) is an especially rigid structure with RMSF of only 0.1–0.2
nm. The flanking regions, on the other hand, are more mobile and especially the
C-terminal residues show fluctuations of more than 0.6 nm. Previous NMR and
x-ray crystallography studies of human CD44 HABD consisting of residues 20 to
178 observed high flexibility particularly for residues 170 to 178 [15]. Therefore, the
result obtained here with the residue 20 to 169 protein construct are well justified.
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Figure 5.7: The upper left plot gives the RMSF profile of the protein in simulations S1
( ), S2 ( ), S3 ( ), and S4 ( ). The upper right plot represents the RMS fluctu-
ations of the disordered protein in the simulation S17. The lower row gives the hydrogen
bond and minimum distance profiles for the CD44-HA interaction in the simulation S18.
The conformational states of the C-terminal tails are given in the legends.
RMSDs were also analyzed as a function of time from simulations S1, S2, S3, and S4
and they support the above observations of a stable protein (data not shown).
To further assess the significance of the apparent instability in the C-terminus, we
induced the PD conformation, where the end residues are freed from the knot-like
O-conformation, by manually displacing the residues 150 to 169 from their original
coordinates, as shown in the right hand side of Figure 5.8. This was done in two
different systems: CD44 without a ligand (simulation S17) and CD44 complexed
with HA8 (simulation S18). The RMSF profile (Figure 5.7) demonstrates that the
stability of the protein was not markedly affected upon the O-to-PD transition.
While the C-terminal residues from 141 to 169 gain conformational flexibility and
experience the unfolding of the β9 strand, the Link module remains unaffected by
these perturbations.
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A) B)
Figure 5.8: Two characteristic conformation changes in CD44 HABD. A) shows the local
flipping of the Arg41 side-chain, so that red represents the B-form and green is the A-form.
Similarly, B) describes the more profound relaxation of the C-terminal tail. The red is the
PD conformation, whereas the green is the crystallographic O-form.
During the course of the simulation S18, the initially disordered C-terminal tail
binds the HA8 oligomer complexed with CD44 at 90 ns. This interaction is then
maintained through the rest of the 500 ns simulation, implying that the reached
binding conformation was stable. Indeed, the hydrogen bond and the minimum
distance profiles in Figure 5.7 demonstrate that the basic residues of the C-terminal
end spontaneously bind to the ligand. The C-terminal amino acids most readily
interacting with the HA are Lys158, Glu160, and Asp167.
Recently, Favreau et al. [18] acquired the same results with a corresponding sys-
tem of human CD44 HABD with HA8 and came to the conclusion that freeing the
basic amino acids of the C-terminus will result in high affinity binding. We note
that while the PD conformation obviously enhances the binding of HA octamer, it
is worthwhile to compare these findings to the binding of HA16 to a crystallographic
O-state conformation. Consequently, HA16 seems to be long enough to bind these
basic residues even when the protein is in the O-state (Figure 5.1), thus suggesting
that the O-to-PD transition would only matter for very short (< HA16) ligands.
Our results thereby support the early findings by Peach et al. [13] fortifying the role
of the basic residues in the C-terminus, but at the same time question the biological
importance of the O-to-PD transition.
Another conformational change characteristic to CD44 is the tilting of the Arg41
side chain (Figure 5.8). We observed this spontaneous A-to-B transition in only
two occasions. The first one was, rather surprisingly, in the simulation S7, where
no HA was present. Previously, Jamison et al. [17] and Favreau et al. [18] have
claimed that the B-form is the high affinity conformation and that it is only stable
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Figure 5.9: The observed minimum distance between the binding site (the Arg78 back-
bone atoms) and HA16 calculated from simulation S2, so that the first 400 ns represent
the A-form and the next 400 ns (400–800 ns into the trajectory) represent the B-form.
when interacting with a strand of HA. Our simulation data, however, clearly suggest
that the B-form is stable even in the absence of the HA ligand, because once the
transition had commenced, the protein remained at this conformation for the rest
of the simulation (a total of 600 ns).
The second A-to-B transition took place in the simulation S2, which included
an HA8 oligomer docked to the binding groove. Strangely enough, the initially
stable CD44-HA interaction was suddenly disconnected after the transition to the
B-form occurred at 400-ns mark in the trajectory. In comparison, in the A-form,
HA maintained a very narrow distance distribution to the bottom of the binding
groove, as plotted in Figure 5.9. Furthermore, after 1600 ns of simulation, the Arg41
side chain spontaneously flipped back to its original A-form orientation, meaning
that the protein spent only 1.2 µs in the B-form conformation. This observation is
important regarding the regulation of CD44 function, as it suggests that the B-form
conformation is actually repelling the bound HA. While these findings contradict
heavily with the previous endeavors of deciphering this phenomenon, they are also
supported by the fact that in the previous NMR studies of CD44 HABDs in the
presence of HA6, the most prevalent B-form Arg41 side chain rotamers were never
recorded [19]. This surprising finding implies that equilibrium conditions might
indeed favor the A-form.
A key difference in the A-to-B transition is the tilting of the β1-α1 loop, thus
allowing the B-form to commence. To justify our observations, we calculated the
characteristic Ramachandran (ψ,φ) plots for residues 38 to 45, belonging to this
loop. It was done as follows. First we mapped the angle values of each protein
backbone ψ,φ dihedral pair in every simulation timeframe. The values were then
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Figure 5.10: Protein backbone (φ,ψ) distributions of the loop residues 39 to 42. The
values are normalized so that the red contours represent the highest occurrence probabili-
ties.
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plotted into an occurrence matrix to obtain the contour plots shown in Figure 5.10.
Only the Ramachandran plots of residues 40 to 43 show a considerable change
between the A and B-forms. This and the changes itself are consistent with the
observations made by Jamison et al. [17], thus verifying that we, indeed, deal with
the same phenomenon.
Another characteristic feature of the A-to-B transition is the spatial orientation
of the Arg41 side-chain. To measure the changes in this orientation, we calculated
the Arg41 side-chain rotamer populations by computing the relative occurence of
each possible side-chain dihedral combination before and after the A-to-B transitions
from the simulations S2 and S7. These rotamer populations are presented in Figure
5.11 and they are clearly more heterogenic (i.e. have wider distributions) in the A-
form than in the B-form. In the former, the 12 most probable rotamers account for
85.5 % and 73.3 % of the total sampling when HA is absent or present, respectively,
whereas in the latter the same percentages are 97.5 % and 97.9 %. Furthermore,
the most probable rotamers in the B-form are not present in the A-form. These
observations are again consistent with the ones made by Jamison et al. [17], albeit
they have an even narrower distribution representing the B-form. However, their
simulations cover timescales of only 20 ns and therefore might not be enough to
gather the sampling data that fully represents the underlying phenomena.
As Figure 5.11 shows, the effect of HA’s presence is only minor. When it is
bound, the rotamer distribution is slightly more narrower, which may suggest that
the B-form is more stable in that case or imply that the movements of the Arg41
side-chain are just more constricted in the presence of a ligand.
Based on the whole simulation data, the HA ligand is able to assume two different
binding orientations or modes inside the binding groove. Intriguingly, these seem
to depend at least to some extent on the conformational state of the protein. For
instance, in the A-form by far the most common orientation is the one where the HA
oligomer aligns itself over the Arg41 side chain (green strand in Figure 5.12), so that
the individual carbohydrate rings orient parallel to the plane formed by the Arg41
side-chain. The second orientation is more exceptional, but it can be induced, for
example, by linking a pentasaccharide to Asn100. Now HA is located on the upper
part of the binding groove and its carbohydrate rings settle perpendicularly relative
to the plane formed by the A-form Arg41 side-chain (red strand in Figure 5.12).
Furthermore, in this orientation HA prefers to interact with the Arg78 side chain,
whereas in the more common one it connects to Arg41. Interestingly, it seems that
only the perpendicular orientation allows the B-form to commence. A reason for
this is most likely that in the parallel mode the Arg41 side-chain is forced down
by the interacting HA strand, so that the side-chain is unable to flip towards the
binding groove. All in all, this finding is important as the orientation of the ligand
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Figure 5.11: Arg41 side-chain rotamer populations in the A-form and the B-form from
the simulations S2 and S7. Rotamer dihedrals are classified according to the gauche con-
formation, so that gauche minus (gm) is −120 ◦ to 0 ◦, gauche plus (gp) is 0 ◦ to +120 ◦,
and trans (t) is < −120 ◦ to > +120 ◦.
may play a role in the long-term stability of the binding interaction.
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Figure 5.12: Figure illustrating the two possible binding orientation of the HA. The
parallel orientation is given in green and the perpendicular orientation in red. Arg41 is
also shown for the sake of clarity.
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6. CONCLUDING REMARKS
The objective of this Thesis was to study the binding between the CD44 protein
and the HA polysaccharide. We employed computational molecular dynamics simu-
lations to explore the role of ligand size, glycosylation, and conformation changes on
the regulation of the binding interactions between the two molecules. Importantly,
we are the first to implement a model of glycosylated CD44 and thus the first able
to investigate these novel areas of CD44 biology. Additionally, unlike previous com-
putational studies, our simulations cover timescales of microseconds, enabling us to
have a more comprehensive view into the conformational changes of the protein.
We measured the binding free energy for the HA tetramer and the octamer by us-
ing the umbrella sampling method. The result for the former is roughly 7.5 kJ mol−1,
meaning that it cannot form a stable interaction with the protein. Subsequent analy-
sis of the residual binding profiles reveals that while the principal binding site formed
by Arg41 and Arg78 attracts the ligand the most, the residues 108 to 114 from the
β5-β6 loop are required to stabilize the interaction. This observation thereby gives
a structural explanation to the low-affinity binding of the tetramer, which is too
short to interact with these flanking residues. In comparison, the octamer engages
the protein with a binding free energy of at least 25 kJ mol−1, which corresponds
well to an experimentally determined dissociation constant [191]. Given that the
clustering of the receptors most likely increases this affinity even more, the obtained
value seems rather high in order to reversibly facilitate processes such as the rolling
of leukocytes. Therefore, we were left with a question of what mechanism, if any,
controls the CD44’s binding affinity for longer HA polymers.
CD44 was glycosylated by attaching the core pentasaccharide to each of the
residues Asn25, Asn100, and Asn110. Notably, from these the Asn25-linked carbo-
hydrate was the most probable to interfere with the binding of HA, as it assumed
a conformation that formed a cover over the principal binding groove. Indeed, a
careful analysis of the simulation data and calculation of the free energy profiles for
the adsorption of the HA octamer show that the Asn25-linked core pentasaccharide
partially masks the native binding site, resulting in a 40 % drop in the binding free
energy. Residual binding profiles also confirm the reduced binding affinity. The
Asn100-linked core pentasaccharide seems to, on the other hand, strengthen the
binding by forming several hydrogen bonds with another free end of the bound lig-
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and, whereas the Asn110-linked carbohydrate has no apparent effect. Our results
therefore support the idea of site-specific functions of glycosylations.
Previous spectroscopy experiments and computer simulations have observed two
distinct conformation transitions in CD44 HABD. The first one is a local tilting
of the Arg41 side chain at the main binding site, whereas the second is a much
broader relaxation of 19 amino acids in the C-terminal tail. We induced the latter
transition manually and found that due to the increased conformational flexibility
in the C-terminal end, it is able to bend over to the binding groove and form several
direct interactions with the bound ligand. Notably, Favreau et al. [18] made the
same observation in a very recent MD simulation study. However, comparing the
PD-state residual binding profiles for HA8 and O-state profiles for HA16 shows that
the O-to-PD transition is meaningful only for short HA fragments, as HA16 is able
to bind the C-terminal amino acids already in the O-conformation. Our findings
therefore question the biological and physical importance of this transition. In fact,
it is somewhat surprising that none of the previous studies have addressed this issue,
because it is doubtful that the HABD would assume the knot-like O-conformation
through normal folding, given that the C-terminal end is the part that connects
to the extracellular stem region in an intact protein. Speculatively, it is possible
that expressing HABD as an individual soluble component, without the rest of the
protein, results in the protein misfolding to the O-form. Moreover, the O-form might
also be a bias caused by the crystallization process, as the available NMR structures
are in the flexible PD-form [19]. Nevertheless, these ideas remain to be clarified in
future studies.
We also observed the more local A-to-B transition in two simulation trajectories.
Most of the previous studies have correlated the "closed" B-form to define a high-
affinity state for the binding of HA. Oddly enough, we observed the B-form to repel
the otherwise stably bound HA, and furthermore that the presence of a bound ligand
is not even a necessity for the transition to occur. Now, combining the above result
with the previously observed strong binding affinities, it is tempting to speculate
that the B-form is actually an intrinsic molecular mechanism of regulating the CD44-
HA interaction by detaching the docked ligand at certain intervals. Yet, the detailed
molecular description of this B-form-induced detaching is missing. One hypothesis
could be that the colliding Arg41 and Arg78 side chains in the binding site would
disrupt the hydrogen bond network with the ligand and drive it to detach. These
ideas, however, still require further investigation.
All in all, we found two possible mechanisms, a glycosylation in Asn25 and a
local conformation change in the principal binding site, to regulate the otherwise
somewhat strong binding affinity. From these, glycosylation is probably a more long-
term alternative for this task, as it requires enzymes specialized to covalently linking
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the special carbohydrates. Most likely the glycosylation itself is carefully regulated
in situ at the endoplasmic reticulum or Golgi complex to allow the cell to maintain a
specific receptor population at the cell surface. The A-to-B conformation transition,
on the other hand, seems to act as a in-built control mechanism. Without this kind of
molecular parking meter the interaction with HA, facilitated by receptor clustering,
would be too strong and thus unable to support normal migratory functions.
Similar observations have not been made by the previous computational studies.
Therefore, we recognize that our results are highly controversial, yet they are also
well justified. The previous studies use both mouse and human CD44 HABDs when
claiming the B-form is the high-affinity state, meaning that it is not a probable
reason for the conflicting findings. In fact, it seems that the only apparent difference
in the simulation platform is that both Jamison et al. [17] and Favreau et al. [18]
were employing a CHARMM [192] force field. Although the choice of the force
field should not affect the results, it cannot be totally ruled out either. More likely
the explanation lies in the simulated timescales and the applied restraints in the
previous studies. In other words, Jamison et al. [17] used only 20 ns simulation
windows to sample the free energy of the A-to-B transition, whereas Favreau et
al. [18] restrained the HA oligomer to the binding groove when sampling the same
process.
Although this Thesis shows how the binding of HA to its CD44 receptor is regu-
lated and is able to explore novel areas of CD44 biology, it also leaves some funda-
mental questions open. First and foremost, why does the B-form repel the ligand?
Second, can there be an interconversion between the parallel and perpendicular
orientations of the bound HA chain to allow the B-form to commence?
We plan to answer these questions by controlling the orientation of the Arg41 side
chain with steered MD methods. Furthermore, to fully explore the role of the O-to-
PD conformation transition and to eventually have a viable model of the glycocalyx,
we need to have the structure of the whole protein, or at least a representative
analog, embedded in a lipid bilayer mimicking the physiological composition of the
cell membrane. We can also improve our description of the glycosylations to be even
more realistic by adding terminal sialic acids to the distal mannoses of each attached
core pentasaccharide. Indeed, while this study provides interesting and novel insights
into the regulation of protein-carbohydrate interactions, the true work to unravel
the sugar puzzle has only just begun.
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